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CHAPTER 1: HYPERTENSION ASSOCIATED WITH FRUCTOSE AND HIGH SALT: RENAL
AND SYMPATHETIC MECHANISMS
(This Chapter contains previously published material. See Appendix B.)
INTRODUCTION
Hypertension is a multifactorial condition rather than a single disease entity whose
onset can be brought about through a variety of factors originating from environmental,
dietary, or hereditary factors. The complex interplay of these components has frustrated our
understanding of hypertension, despite decades of research spent attempting to identify its
causes and develop viable treatments. Even today, less than 20% of all hypertensive cases
have a known etiology (referred to as secondary hypertension) with the basis for the
remaining majority of cases being unknown (referred to as primary or essential
hypertension) [1, 2]. Studies of the U.S. population have found that 29% of adults are
hypertensive, and this number is only expected to increase dramatically in the near future
[3]. Unfortunately, elevated blood pressure is becoming increasingly prevalent in people
under the age of 40 years [4]. Despite the fact the proportion of individuals with controlled
blood pressure (systolic < 140 mmHg; diastolic < 90 mmHg) in the U.S. has increased from
28.4% to 43.5%, in low and middle-income countries control of blood pressure has actually
decreased to 7.7% [5, 6]. Indeed, even mild increases in either systolic or diastolic pressure
(< 10 mmHg) are accompanied by increases in mortality rates [7]. The increased prevalence
of hypertension has coincided with an equally sharp increase in the incidence of chronic
kidney disease that has been attributed, at least in part, to substantial changes in dietary
intake and sedentary lifestyle [4, 8]. Hence, there has been an increased effort to develop
new models of hypertension that better reflect the environmental and dietary behaviors of
modern society. Several models of diet-induced hypertension exist that are well established,
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namely those high in fat or sodium [9, 10]. Models of metabolic syndrome induce a
constellation of medical conditions accompanying insulin resistance such as obesity,
hyperglycemia, hypertension, and dyslipidemia [11]. Given the widespread use of fructose
as a sweetener in food products, several recent reviews have discussed the impact of fructose
ingestion on obesity and hypertension within the metabolic syndrome [12, 13] and the
hormones involved [14]. The present review focuses on recent interest on the consequences
of even mild fructose consumption independent of full-blown metabolic syndrome with
particular attention to the role of the kidney and the sympathetic nervous system on blood
pressure.
FRUCTOSE CONSUMPTION, HYPERTENSION, AND MORTALITY
Total fructose consumption includes that which is found in high fructose corn syrup
(HFCS) and sucrose. Generation of HFCS began in the late 1950s when it was discovered that
glucose, hydrolyzed from corn starch extracts, could be partially converted to fructose
through enzymatic isomerization [15]. Over time, this process was industrialized and led to
the development of the corn-derived sweetener, HFCS, which can be synthesized with
varying ratios of fructose to glucose content. Ease of synthesis, comparable flavor, and low
cost of this ingredient have contributed to its widespread use as a sweetener [16]. Between
1970 and 2006, fructose consumption drastically increased, amounting to approximately
50% of all per capita added sugar consumption. This increase is accounted for solely by an
exponential increase in free fructose consumption in the form of HFCS. During this time,
caloric intake from total sugar (HFCS, sucrose, and other natural sugars) and fats increased
significantly contributing to a 41% increase in total carbohydrate intake, of which fructose
consumption provided a primary source [17].
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HFCS appeals to nearly every demographic leading to its widespread use in food
products. Statistical analysis of data collected in the National Health and Nutrition
Examination Survey (NHANES I-III) determined that HFCS is most heavily consumed in the
form sugar-sweetened beverages, and this trend is consistent throughout all age groups and
sexes. Although a recent meta-analysis of three prospective studies fails to show incident
hypertension associated with fructose, these studies relied on self-reports of dietary intake
and physician-diagnosed hypertension and did not include concurrent sodium intake [18].
In contrast, another meta-analysis (n = 240,508) that includes data from the Coronary Artery
Risk Development in Young Adults (CARDIA) cohort (n = 240,508) [19] and quoted by the
recent American Heart Association update on stroke reports a 12% greater risk of
hypertension with consumption of sugar sweetened beverages when controlled for sex, age,
race, BMI and smoking behaviors [20]. Compared with the increased risk associated with
more traditional factors such as alcohol consumption (61%), smoking (21%), and red meat
intake (35%) and sedentary life style (48%) [21-24] or the non-traditional risk of stress (512%) [25], the risk associated with fructose intake may appear small but is nonetheless real.
Whether the risk of hypertension associated with fructose is modified by combination with
higher sodium intake has not yet been rigorously evaluated in humans, but the role of
combined intake in preclinical studies is discussed below.
Adolescents and young adults are the highest consumers overall, and people in lower
income population sectors are more likely to consume HFCS than those in more affluent
demographic groups [13]. The rise in fructose consumption over the past several decades
has been accompanied by an increase in obesity in the United States, and these rates parallel
those of hypertension in a nearly linear relationship between body mass index and blood
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pressure [26, 27]. Although several human studies have shown that high fructose
consumption contributes to weight gain and blood pressure elevation, there is still
controversy over the extent to which HFCS consumption is correlated with the historical
obesity and hypertension trends [28]. Factors such as overall increase in national
carbohydrate consumption make it challenging to discern increased fructose intake as a
primary etiologic source for these disease states [17]. Nevertheless, the ingestion of fructose
induces several physiologic responses that favor weight gain and increased blood pressure.
The most recent NHANES III survey found that as of 2004, the average daily intake of
fructose (49 grams) in the U.S. equated to 9.1% of total energy intake [17]. Interestingly,
commercially available drinks using HFCS have up to 140 calories from added sugars per 12
fluid ounce container. Given the most commonly used HFCS composition of 55% fructose
and 45% glucose, this amounts to approximately 25 grams or 100 calories from fructose
alone. This quantity from one drink alone nearly surpasses the American Heart Association
recommendation of only 150 and 100 calories from added sugars per day for men and
women, respectively [29]. Animal studies designed to model this trend in human dietary
intake have used various dietary fructose compositions - many of which exceed 60% of total
daily caloric intake [30-32]. Increased fructose ingestion in either humans or animal studies
have demonstrated significant hemodynamic changes even after limited periods of time [28,
33, 34]. Interestingly, most animal studies were not accompanied by significant increases in
body weight, suggesting that factors apart from obesity may contribute to the hypertensive
phenotype [30, 31]. Chronic animal models using more moderate fructose intake that is
consistent with heavy human consumption (15-20% of daily caloric intake) demonstrate
cardiovascular and metabolic changes similar to human subjects, although the timeline by
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which these occur may be skewed [35, 36]. The role of endothelial dysfunction has been
reviewed in detail [37, 38]. Mechanisms involved in the early phases of sodium absorption
by the intestine have been studied to a greater extent [39]; however, renal sodium
reabsorption [40], the renal renin-angiotensin-aldosterone (RAS) system [41], and
sympathetic nervous system [32, 42] have received more limited attention.
FRUCTOSE INFLUENCE ON SODIUM HANDLING AND BLOOD PRESSURE
Fructose influences on gastrointestinal sodium absorption
Sodium homeostasis is a critical component of blood pressure regulation and has
been linked to various cardiovascular and renal complications, including hypertension [4346]. Glucose intake is coupled to Na+ transport via the luminal sodium-glucose-linked
transporters 1 and 2 (SGLT1 and SGLT2). Intracellular glucose concentration is largely
maintained through the glucose transporter 2 (GLUT2) isoform along the basolateral
membrane. Chronically, fructose and glucose (but not other sugars) lead to an increase in
GLUT2 protein expression along the basolateral membrane [47]. Similar to GLUT5, GLUT2
has a much lower affinity for glucose than other isoforms and therefore functions primarily
as a fructose transporter [48]. Fructose transport is facilitated by a downhill concentration
gradient between the intestinal lumen and intracellular space [39, 49, 50].
On the other hand, sodium absorption occurs throughout the small intestine via a
variety of transport systems. SLC26A6 (human), also known as the putative ion transporter
1 (PAT1), is a multifunctional apical chloride/base exchanger that increases with fructose
feeding in both the jejunum [39, 51] and kidney [52]. The function of PAT1 is coupled with
that of the intestinal Na/H exchanger 3 (NHE3) so that Na+ is reabsorbed with Cl- in an
electroneutral manner [53, 54]. The presence of fructose amplifies NHE3 function, thereby
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enhancing absorption of Na+ and secretion of H+ [39, 40, 42]. PAT1 also co-localizes with
GLUT5 (Slca5), a member of the glucose transporter family, with low affinity for glucose and
high affinity for fructose. GLUT5 is the dominant fructose transporter in the jejunum.
Despite the changes in both sodium and sugar transporters, the impact of fructose on
overall gastrointestinal absorption and ultimate fecal excretion of sodium has been given
scant investigative attention. An increase in dietary sodium does not increase absolute fecal
sodium excretion in Sprague Dawley rats independent of whether the high sodium chow is
delivered with glucose or fructose in the drinking water or with water alone. Gastrointestinal
sodium absorption increases as dietary intake of sodium increases regardless of the
presence or type of sugars in the diet. Thus, the task for excretion of the greater total body
sodium content relies on the kidney. Notably, urinary sodium excretion is significantly
diminished in fructose-fed rats resulting in a positive sodium balance [41]. The renal
mechanisms that are understood to date are detailed below.
Fructose influences renal sodium reabsorption and RAS
The bulk of Na+ reabsorption in the mammalian kidney occurs in the proximal tubule,
which is responsible for reabsorption of 60-70% of all Na+ and fluid filtered by the
glomerulus [55]. Similar to the intestine, GLUT2, GLUT5, NHE3, and several isoforms from
the SGLT family facilitate the reabsorption of Na+. Proximal tubule Na+ reabsorption is reliant
on secondary active transport by co-transporters such as NHE3 and SGLT isoforms,
particularly SGLT2 [56]. Fine tuning of ionic concentrations and gradients is critical to blood
pressure homeostasis. Perturbation such as augmented proximal tubule Na+ reabsorption
results in increased fluid reabsorption, leading to a net positive sodium balance predisposing
to hypertension. This mechanism has been linked to hypertension in spontaneously
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hypertensive rats [57] and Dahl salt-sensitive rats [58]. In carefully executed balance studies,
Gordish et al. [41] showed that rats given 20% fructose in their drinking water and placed
on high salt diet displayed significantly greater cumulative Na+ balance compared with rats
given only water or 20% glucose in their drinking water. These findings strongly supported
a role for fructose-feeding on renal Na+ balance. Notably, except for elevated triglyceride
levels in the fructose-fed high salt group, there were no differences in fasting plasma glucose
and body weights between fructose-high salt-fed rats and glucose or water controls either
with standard or high salt intake [41].
In the proximal tubule, the large proportion of filtered Na+ and bicarbonate (HCO3-)
reabsorption is linked to Na+/H+ exchange, via NHE3 [59]. Acute in vivo microperfusion
studies of proximal tubules from Wistar rats exposed to fructose revealed enhanced NHE3
activity. The increase in NHE3 activity was corroborated by in vitro studies showing greater
Na+ dependent H+ flux in the presence of fructose associated with diminished PKA activity in
cultured LLC-PK1 cells, a porcine cell line [60]. Fructose, but not glucose, increased NHE3
activity by isolated rat proximal tubules via a PKC-dependent pathway and further
potentiated the effects of picomolar concentrations of angiotensin II (Ang II) to increase
Na+/H+ exchange. Na/K-ATPase activity did not change [40]. Moderate amounts of fructose
consumption (approximately 40% of daily caloric intake provided as a 20% fructose solution
in drinking water) increased tail cuff blood pressure in rats. Proximal tubule expression
levels of NHE3 increased significantly in the fructose-fed compared to that of control rats,
whereas α1 subunit of the basolateral Na/K-ATPase did not. Moreover, proximal tubules
isolated from these rats also showed enhanced Na+ reabsorption that was potentiated by Ang
II [61, 62].
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The proximal tubule thus appears to become sensitized to Ang II via a PKC
mechanism, to which the addition of high Na+ intake leads to substantial reabsorption rates.
Further, this sensitization extends beyond the proximal tubule into the thick ascending limb
and other Na+ transport mechanisms in the distal nephron, although studies have reported
some conflicting results. An early study with 65% dietary fructose failed to observe a change
in overall NKCC2 abundance in the kidney [63]. In vitro and in vivo studies have shown
similar effects on Na+/K+/2Cl- co-transporter 2 (NKCC2) expression and activity. Acute in
vitro administration of fructose to the thick ascending limb increases NKCC2 activity by
increasing protein expression and not phosphorylation along the apical membrane [64].
Chronic in vivo studies using furosemide, an NKCC2 antagonist, to measure acute diuretic
and natriuretic responses following NKCC2 blockade found that high fructose-induced
hypertension led to significant increases in urine output as well as in urinary potassium,
chloride, and sodium concentration. This was reflected by significant increases in NKCC2
mRNA and protein expression [65]. Together, these alterations in transporter expression
and activity throughout the nephron facilitate plasma volume expansion which is
responsible, at least in part, for the observed hypertension.
The importance of sensitization to Ang II also cannot be understated. Several
preclinical studies have shown that even moderate consumption of fructose and Na+ can
have considerable adverse effects on blood pressure [41, 42, 61, 66]. With the profound
increases in Na+ retention observed in the various models of fructose-induced hypertension
with expected extracellular volume expansion, it would be anticipated that plasma renin
activity (PRA) would be suppressed. Further investigation by others reported blunted
suppression of PRA in Sprague Dawley rats given 20% fructose for one week, followed by
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one week of fructose plus 4% NaCl diet [41, 66]. In contrast, extending the high salt intake
period to 3 weeks, Soncrant et al. confirmed the elevation in blood pressure using telemetric
monitoring and were able to demonstrate inhibition of PRA and plasma Ang II in fructosefed rats [42]. Thus, it appears that PRA which is typically inhibited by either high blood
pressure or expanded extracellular volume requires a longer period of exposure to either of
these inhibitory influences in the context of high fructose intake. In other words, a much
greater expansion of extracellular volume and, therefore a longer period of positive
cumulative Na+ balance, may be required to inhibit renin secretion with concomitant
fructose-feeding.
It is also possible that intrarenal RAS contributes to hypertension and increased Na+
reabsorption with fructose feeding. Early studies indicated that renal tissue renin expression
was suppressed in fructose-fed mice [39] yet increased in rats fed 20% fructose for 12 weeks
[65]. Renal tissue Ang II levels were not statistically different from control glucose-fed rats
on high salt diet for 3 weeks despite higher blood pressure [42]. Notably, renal angiotensin
AT1 receptor mRNA was increased in adipose tissue but not kidney after three weeks of high
fructose ingestion [67]. When fructose was given in greater amounts (60 to 66% in the
drinking water) and for longer periods of time (8 to 16 weeks), both Ang I and Ang II as well
as AT1 receptor protein expression was increased in kidney tissue [68, 69]. Alternatively,
the third influence on renin secretion involves sympathetic inputs to the macula densa.
Indeed, switching from standard diet (0.4% NaCl) to high salt (4% NaCl) diet in fructose-fed
rats increases renal sympathetic nerve activity by ~ 50% [42]. Denervation of the kidneys
bilaterally using cryo-techniques further decreased the already suppressed PRA suggesting
sympathetic inputs to the kidney were responsible for the enhanced renin secretion.
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Notably, neither the diets nor denervation altered tissue Ang II content compared with
controls [42].
In addition to the experimental dietary manipulations, some of the variability in these
studies likely stems from methodology used such as the technique for blood pressure
assessment (tail cuff vs telemetry), the time when fructose is initiated relative to the high
salt diet, the length of exposure to each component of the diet, and the methodology for
collection of blood or tissue for measurements of renin, plasma Ang II or their tissue levels.
Regardless of the impact of these factors, the findings that a diet enriched for fructose
sensitizes the nephron to Ang II such that even minimal activation of the RAS can have
profound sodium reabsorption effects.
Fructose influences on the renal sympathetic nervous system
The scientific interest in sympathetic innervation of the kidney has increased recently
after the demonstration of marked reductions in blood pressure in individuals with resistant
hypertension after denervation using the catheter-based approach [70, 71]. Renal
sympathetic nerve activity (RSNA) is significantly increased in many forms of experimental
hypertension (reviewed by Osborn and Foss [72]), reinforcing the vital role of RSNA in blood
pressure regulation. The mechanisms of increased RSNA in the pathogenesis of hypertension
include increased tubular sodium reabsorption and water retention, decreased renal blood
flow and glomerular filtration rate, and increased renin secretion from the juxtaglomerular
cells which activates the renin-angiotensin system [73]. Since moderately high dietary
fructose and salt cause hypertension via similar mechanisms, it has been hypothesized that
sympathetic activity increases in this dietary milieu. In fact, ingestion of fructose has been
shown to result in changes in secretion of hormones that regulate energy balance [74], a shift
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associated with increased sympathetic nervous system activity [75]. The hormone leptin
which promotes satiety is released from adipose tissue cells to maintain energy balance by
promoting satiety. In contrast, ghrelin opposes this action and promotes hunger. Ingestion
of fructose leads to simultaneously increased secretion of ghrelin and decreased secretion of
leptin. After chronic ingestion of excess dietary fructose (over 1 to 4 weeks), fasting plasma
concentrations of leptin are significantly higher [76]. The mechanistic basis for elevated
leptin levels likely stems from fructose-induced fatty acid re-esterification and synthesis of
VLDL-triglycerides. This pathway causes a shift towards the fat-storing mode, prompting the
adipose cells to respond by elevating leptin production. Simultaneously, augmentation of
RSNA occurs initiating the onslaught of hypertension-promoting effects.
Fuctose‐induced endothelial dysfunction
The general mechanisms by which the fructose induces increased sodium absorption
and retention and how this ultimately leads to increased extracellular volume and
hypertension are well defined. The hypertensive states are maintained by two additional
overarching pathologies: increased sympathetic activity (regional and systemic) and
endothelial dysfunction [77]. As noted, increased sympathetic activity to the kidney causes
increased sodium reabsorption as well as blunts inhibition of renin secretion, despite
increased plasma sodium levels. Sympathetic activity to the vasculature produces
vasoconstriction which, in turn, increases arterial pressure. Chronic fructose feeding has
been shown to induce over-activation of the sympathetic nervous system that leads to
increased systemic resistance, accompanied by an increase in plasma norepinephrine.
Increases in arterial pressure in this study were ameliorated by alpha1-adrenoreceptor
blockade [78]. Much of this sympathetic drive is postulated to originate from increased
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plasma insulin levels, which in turn exacerbate insulin resistance and a positive feed-back
loop that promotes further sympathetic drive [32].
While increases in arterial pressure are occurring via sympathetic, humoral, and
volume-dependent mechanisms, additional factors are simultaneously inducing further
endothelial dysfunction that may lead to permanent vascular remodeling. Fructose-induced
hyperinsulinemia leads to disruptions of endothelial systems such as lowered activity and
expression of endothelial nitric oxide synthase (eNOS) and endothelin-1 (ET-1); both of
which alter vascular tone and increase vasoconstriction [36, 79, 80]. Thromboxane A2 and
angiotensin II (Ang. II) are also potent vasoconstrictors whose upregulation have been
observed in fructose studies and have been linked, at least in part, to increased ET-1
expression [81-83]. Each of these vasoactive proteins - ET-1, Ang. II, and thromboxane A2 –
can act independently or in concert to degrade endothelial membrane proteins by way of
matrix metalloproteinase up-regulation. It has been proposed that this pathway of
endothelial dysfunction ultimately leads to further degradation of eNOS and therefore
increased arterial pressure. This situation is true in the context of hyperinsulinemia and has
also been shown in instances of high dietary fructose consumption, where matrix
metalloproteinases isoform 2 upregulation reduces nitric oxide (NO) levels. [84].
EXPERIMENTAL PURPOSE AND DESIGN
In vitro and in vivo research has provided us with extensive knowledge regarding the
pathologies of fructose-induced hypertension. However, much of this research has been
conducted using irrelevantly high quantities of fructose that without question implicate
influential pathologic mechanisms such as hyperinsulinemia and hyperglycemia. The
benefits of using a model with lower levels of fructose to induce states of salt-sensitivity are
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not only particularly relevant to modern consumption trends, but also promote an avenue of
study in which the multifactorial nature of hypertension can be further elucidated without
confounding factors such as insulin resistance. The purpose of this research was to utilize a
model of hypertension such as this to elucidate not only the mechanisms by which it occurs,
but also to determine the extent by which such mechanisms induce end-organ damage. The
studies detailed in the following chapters were designed to investigate the end-organ
consequences of fructose-induced salt-sensitive hypertension in both acute and chronic
settings.
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CHAPTER 2: AORTIC STIFFNESS AND DIASTOLIC DYSFUNCTION IN SPRAGUE DAWLEY
RATS CONSUMING SHORT‐TERM FRUCTOSE PLUS HIGH SALT DIET
(This Chapter contains previously published material. See Appendix C.)
INTRODUCTION
Hypertension prevalence is currently estimated at 46% among adults in the United
States and remains one of the top healthcare and societal burdens [85]. Chronic increases in
arterial pressure contribute to the development of comorbidities and major adverse cardiac
events (MACE) such as stroke, myocardial infarction, heart failure, and renal disease [86].
Despite the urgent need to implement strategies for incidence reduction, the etiologies
underlying the majority of hypertensive states still remain unknown. In addition to genomic
factors, environmental factors including suboptimal dietary habits also contribute to the
development of hypertension. Consumption of fructose has been on the rise due to
increasing use of high fructose corn syrup since the 1970’s for sweetening beverages and
pre-packaged foods [13]. A recent meta-analysis found that individuals consuming sugarsweetened beverages in the highest versus lowest quantile displayed a greater risk for
hypertension [19]. The association between fructose ingestion and hypertension is
potentiated by increased salt intake [87]. Indeed, a typical Western diet is enriched in both
fructose and salt.
Previous work in the fructose-induced salt sensitive hypertension rat model showed
increased reactive oxygen species (ROS) production, diminished nitric oxide bioavailability
and cumulative positive sodium balance [41, 88]. Activation of the renin-angiotensinaldosterone system (RAS) and increased renal sympathetic nerve activity, both of which
promote increased renal tubular sodium reabsorption, have also been implicated as
mechanisms resulting in elevated arterial pressure [41, 42, 62, 66, 89]. Notably, bilateral
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renal cryo-denervation [42] or daily treatment with the superoxide dismutase mimetic, 4hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl

(+T;

Tempol),

reduces

8-isoprostane

excretion and ameliorates the hypertension.[66] In light of these findings, it is possible that
combined fructose and high salt diet may exert a deleterious impact cardiac and vascular
function either directly or indirectly via the elevated arterial pressure. If so, then it would be
important to evaluate whether 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl also
ameliorates cardiovascular function in this model.
Data from the Framingham population highlight that aortic stiffening precedes
hypertension.[90, 91] The force of ejected blood during cardiac systole exerts pressure on
the aortic wall that makes the normal aorta expand and then recoil back during cardiac
diastole. This property of healthy aorta is known as the Windkessel function, or capacitance,
and functionally is responsible for reduction of systolic blood pressure and maintenance of
peripheral perfusion during diastole. As the aorta stiffens such as occurs physiologically in
aging and pathophysiologically in diabetes, obesity and hypertension, it loses the Windkessel
function which is reflected in increases in pulse wave velocity (PWV) [92, 93]. Accordingly,
aortic PWV is one of the most reliable predictors of cardiovascular mortality as
demonstrated by two major meta-analyses [94, 95]. Elastic properties of major vessels can
also be assessed with strain imaging as demonstrated by a recent study describing
reductions in common carotid artery strain as a valuable tool for detection of atherosclerotic
disease.[96] Likewise, a decrease in ascending aortic strain is an independent predictor of
significant coronary artery disease in patients with coronary artery stenosis ≥70% [97].
Given the interdependence of systemic and renal hemodynamics, it is tempting to
speculate that aortic stiffening is expected to have deleterious consequences on the renal
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vasculature. Renal resistive index (RRI) measured with intrarenal Doppler ultrasound is
influenced by complex interactions between vascular wall properties and systemic factors
and can be used to identify vascular dysfunction [98]. Higher RRI is associated with
increased PWV [99] and leads to microvascular damage over time [100]. The effects of
fructose-induced salt-sensitive hypertension on the elastic properties of conduit and
resistance vessels are presently undefined. Even in the absence of hypertension, saltsensitivity in humans constitutes a cardiovascular risk factor [101, 102]. It is unknown
whether fructose predisposes to salt-sensitive hypertension by reduced aortic compliance,
increased PWV and consequential perturbations in renal hemodynamics via the ROS system.
However, such a process could link fructose and high salt ingestion with hypertension and
may explain how fructose induced salt sensitive hypertension leads to systemic and renal
hemodynamic derangements.
In the present investigation, we employed the fructose-induced salt sensitive
hypertension rat model by feeding rats 20% (w/v) fructose for one week, followed by the
addition of 4% NaCl for three more weeks, which results in increases in mean arterial
pressure[42]. We hypothesized that dietary fructose, rather than glucose, in combination
with high salt will lead to aortic stiffening, evidenced by increased aortic PWV, decreased
strain, and decreased distensibility coefficient. This will, in turn, result in an increase in RRI.
We hypothesize that daily supplementation with the antioxidant, 4-hydroxy-2,2,6,6tetramethylpiperidine-1-oxyl, will ameliorate the increase in mean arterial pressure, and
thereby mitigate vascular stiffening. These studies are aimed at identifying the diverse
mechanisms that diminish aortic compliance, impair renal vascular function, and contribute
to hypertension.
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MATERIALS AND METHODS
Animals
Male Sprague-Dawley rats (Harlan Sprague Dawley, Indianapolis, IN) were housed
under controlled conditions (21–23°C; 12 hr light and 12 hr dark cycles, light on at 7 am)
and were permitted ad libitum access to water and standard rat chow containing 0.4% NaCl
until they were enrolled into experimental protocols described below. Complete care
provided to rats was in accordance with the principles of the National Institutes of Health
Guide for the Care and Use of Laboratory Animals. All procedures and protocols were
approved by the Wayne State University Institutional Animal Care and Use Committee
(Protocol #19-01-1001).
Dietary regimen
Upon arrival of animals to the DLAR facilities, all rats were provided ad libitum access
to 0.4% NaCl standard chow (Envigo Teklad, Madison, WI) and normal water. Three to five
days later, hemodynamic telemetry devices were implanted, and rats allowed to recover for
three-four days in single housing. Following previously established protocols, 6,9,10 the rats
were randomized to either 20% (w/v) glucose (Sigma-Aldrich, St. Louis, MO) or 20% (w/v)
fructose (Sigma-Aldrich, St. Louis, MO) and maintained 0.4% NaCl chow. The age of rats at
enrollment was 10-12 weeks and the average weight was 228.6 ± 5.9 g in the control group
and 225 ± 2.5g in the Tempol group. Glucose was provided in the control groups to match
both caloric and fluid intake. The consumption of glucose and fructose was similar
throughout the protocol (~65 kcal per day as carbohydrate). After one week, the rats were
randomly assigned to one of eight groups: 1) glucose and normal (0.4%) salt (Glu+NS), 2),
glucose and high (4.0%) salt (Glu+HS), 3) fructose and normal salt (Fru+NS), 4) fructose and
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high salt (Fru+HS), 5) Glu+NS with the addition of 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (+T) (Glu+NS+T), 6) Glu+HS+T, 7) Fru-NS+T or 8) Fru+HS+T).
To assure that each rat in the groups receiving +T (Santa Cruz, Santa Cruz, CA)
received the full dose, 35 ml of the respective drinking mixture was supplemented with +T,
15 mg/400 g body weight. After the rat completed drinking the allotted antioxidant solution,
a fresh water bottle with the respective glucose or fructose supplement alone was provided.
This approach allowed verification that each rat received its full dose of anti-oxidant and that
fructose or glucose ingestion across all groups was similar. The respective dietary regimens
were continued for three weeks with monitoring of hemodynamic parameters via telemetry.
Surgical procedures
Hemodynamic telemetry transmitter placement. All rats were instrumented with
hemodynamic telemeters at ten weeks of age (~225 g body weight) under ketamine (80
mg/kg) and xylazine (10 mg/ml) anesthesia. An incision was made in the groin and a
hemodynamic telemetry transmitter (TA11PA-C40, Data Sciences International) implanted
by exposing the right femoral artery, temporarily occluding the proximal end, and inserting
the gel-filled catheter attached to the transmitter device into the artery with a 21-gauge
needle. The catheter was advanced into the abdominal aorta and the transmitter tunneled
subcutaneously. The incision was closed using surgical staples. Post-operative analgesia was
provided with buprenorphine SR (0.3 mg/kg subcutaneously).
Vascular catheter placement. At the end of the fourth week (1 week glucose/fructose
+ 3 weeks ± Tempol®), the rats were instrumented with carotid arterial catheters for
hemodynamic monitoring during ultrasonography and for collection of aortic blood at the
conclusion of experiments.
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Telemetry, echocardiography and renal Doppler studies
Data acquisition of hemodynamic parameters was performed using Dataquest ART
software (Data Sciences International, Saint Paul, MN). Measurements of heart rate, systolic
(SBP), diastolic (DBP), and mean arterial pressures (MAP) as well as the derived pulse
pressure (PP) were sampled for 10 sec at a sampling rate of 500 samples/sec every 1 hr for
the remainder of the 3-week protocol. The average of hemodynamic recordings initiated
during the last three days of the week during which the rats were on glucose or fructose and
0.4% NaCl were taken as baseline. Once assigned to one of the eight groups (see above),
hemodynamic measurements over the next three weeks were taken for 24 hr beginning at 7
am (lights on) during Mondays and Thursdays in order to avoid cage cleaning days and
disruptions (e.g., weekend changes in veterinary staff) that could impact the parameters as
well as conserve transmitter battery time. Values are the 24-hr average for a given day.
Two days after placement of vascular catheters, echocardiography and renal Doppler
scans were completed by an investigator blinded to the group assignments. Blood pressure
and heart rate were monitored continuously with PowerLab (ADInstruments, Colorado
Springs, CO) connected to the LabChart 8.0 software.
Rats were anesthetized with 3% isoflurane in an induction chamber, and
maintenance of anesthesia was achieved with 1.5% isoflurane delivered via a nose cone.
Scans were performed on the heated platform (Fujifilm Visualsonics, Inc., Toronto, Canada)
in a supine position with all four limbs secured to ECG electrodes with tape. Fur was removed
from the chest and abdominal areas first by shaving the area followed by a cream depilatory
(Pharmaceutical Innovations, Newark, NJ), before applying contact gel preheated to 37°C.
Body temperature was monitored using a rectal probe. Echocardiographic recordings were
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made according to standard methods[103, 104] at the conclusion of the three-week dietary
intervention. Images were acquired using a Vevo3100 with an MX-250S transducer (Fujifilm
Visualsonics Inc.). A parasternal short axis view was used to obtain images in M-mode at the
level of papillary muscles to assess systolic function and left ventricular dimensions. Left
ventricular diastolic function was ascertained using pulse wave Doppler recordings of
transmitral flow velocities aligned in the apical four chamber view. Aortic PWV was
determined using B-mode and pulse wave Doppler of aortic flow velocities at two positions
along the aortic arch [105]. Briefly, the time to initiation of flow was determined relative to
the ECG and the difference calculated. The distance between the two flow positions,
determined along the B-mode image, was then divided by the time to calculate the PWV.
The renal resistive index (RRI) was ascertained using pulse wave Doppler imaging of
flow through the left main renal artery. The RRI was calculated as the difference between the
peak systolic and minimum diastolic velocity, divided by the peak systolic velocity [98].
Aortic distensibility and strain were derived from the B-mode images. Some measurements
were not able to be technically ascertained in each animal due to anatomical constraints.
Data analysis was completed offline in blinded fashion using VevoLab and VevoVasc
software (Fujifilm Visualsonics, Inc.).
After all scans were completed, the rats were permitted to recover from isoflurane
anesthesia and allowed to regain normal activities for ~4-6 hr. Arterial blood was then
collected in the conscious animals using the carotid catheter for hormone analyses. Blood (1
ml) was taken over 90-sec period into pre-chilled tubes containing 50 µl sodium
ethylenediaminetetraacetic acid (EDTA) for PRA. Another 1.5 ml of blood was taken into a
separate pre-chilled tube with 120 µl of 500 mM sodium EDTA, 125 mM phenanthroline, 1
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mM phenylmethanesulfonyl fluoride, 20 mM pepstatin, 1 mM enalapril and 10X phosphatase
inhibitor cocktail for Ang II. The blood was immediately centrifuged at 3000 rpm at 4°C, and
the plasma stored at -70°C until assay.
The rats were then euthanized with pentobarbital (100mg/kg) and hearts and
kidneys harvested and weighed while keeping them cold in saline. The renal cortex was then
rapidly and sharply dissected, and the tissue frozen at -70°C until analyzed for tissue Ang II.
Hormone assays
All tests were performed on blood samples obtained simultaneously between 1 pm
and 4 pm. Non-fasting blood glucose concentrations were measured with One Touch Ultra 2
(Lifescan, Switzerland). Plasma renin activity (PRA) (IBL International, Hamburg, Germany)
and insulin (Cayman, Ann Arbor, MI) were measured by enzyme-linked immunosorbant
assays according to the product directions. Plasma and tissue angiotensin II (Ang II)
concentrations were assessed by radioimmunoassay as previously described by our
laboratory [106].
Analyses and statistics
Heart rate and arterial pressures were collected using Dataquest ART software (Data
Sciences Intl, St. Paul, MN) and averaged over a 24 hr period. All analyses were performed
by a researcher blinded to the group assignments. Results are presented as mean ± SE.
Comparisons among groups were completed with one-way ANOVA; comparisons among
groups over time were accomplished using two- factor ANOVA. A repeated measures design
requires that every participant participates in every condition of the experiment, historically
called a within-subjects design. Our data was unbalanced, that is, there were slightly
different but unequal sample sizes across each group since some procedures were not able
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to be performed in each animal due to technical reasons (e.g., catheter malfunction). The
repeated measures design drops sample sizes in the analysis until the same, or equal,
numbers are in each group across all time points. Ideally the repeated measures design (with
time point) would be preferred. However, this selection of analysis would drop the already
small sample size until the numbers were equal across all time points and in each group
observed – until they all have the same sample size. The two-factor approach (group and
time point) allows us to keep all the data available and conduct mean comparisons, using a
Sidak post hoc test for multiple pair-wise comparisons. Homogeneity of variance was
checked and verified using Leven’s test. Comparisons of ultrasound parameters between
Fru+HS and Fru+HS+T groups were done using Student’s unpaired t-test. Differences were
deemed statistically significant when the P-value was less than 0.05.
RESULTS
Baseline body weight and heart weight of fructose-fed and glucose-fed rats with and
without antioxidant supplementation were similar. Kidney weights were significantly
greater in control fructose-fed rats on either normal or high salt diets. In +T-treated rats,
mean kidney weights were also higher but the differences were only significant for the left
kidneys since right kidney weights displayed greater variability (Table 1).
Baseline SBP, DBP, MAP and heart rate were similar across all groups (Table 2.2).
Baseline PP appeared to be greater in the Fru+HS group but this did not achieve significance
(P = 0.16). SBP and MAP increased significantly after three weeks of high salt diet in fructosefed but not glucose-fed animals; supplementation with antioxidant prevented this increase
(Figure 2.1). After three weeks, the change in DBP, PP and heart rate did not differ among
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Table 2.1: Rat, Kidney and Heart Weights for All Rat Groups.
N

Initial Rat Body
Weight (g)

Glu+NS
Glu+HS
Fru+NS
Fru+HS

8
12
8
10

230 ± 8
224 ± 5
227 ± 7
226 ± 5

Glu+NS+T
Glu+HS+T
Fru+NS+T
Fru+HS+T

10
12

222 ± 5
228 ± 8

Final Rat Body
Weight (g)
Control
327 ± 7
329 ± 8
330 ± 13
313 ± 5
Tempol
332 ± 10
329 ± 5

Kidney Weight
Left
Right
(g/kg BW)
2.9 ± 0.1
2.9 ± 0.1
3.1 ± 0.1*
3.2 ± 0.1*
2.9 ± 0.1
2.8 ± 0.1

2.9 ± 0.2
2.9 ± 0.3
3.2 ± 0.3*
3.1 ± 0.3*
2.9 ± 0.2
2.9 ± 0.3

Heart Weight
(g/kg BW)
3.8 ± 0.8
3.9 ± 0.5
4.1 ± 0.7
3.9 ± 0.4
3.7 ± 0.4
3.9 ± 0.4

9
224 ± 6
329 ± 9
3.2 ± 0.1†
3.2 ± 0.2
3.7 ± 0.4
9
222 ± 5
337 ± 14
3.1 ± 0.1†
3.1 ± 0.4
3.7 ± 0.4
Glu+NS, 20% glucose+0.4% NaCl; Glu+HS, 20% glucose+4% NaCl; Fru+NS, 20% fructose+0.4% NaCl; Fru+HS,
20% fructose+4% NaCl; +T, indicates addition of 15 mg/400g BW Tempol®; BW, body weight. Values are mean
± SE. *P < 0.05 vs corresponding glucose-fed group. †P < 0.05 vs corresponding glucose-fed plus Tempol® group.

Table 2.2: Baseline Hemodynamics and Changes after 3‐Week Diet Regimen

Group definitions as in Table 1. Values are mean ± SE. * P < 0.05 vs Glu-NS; ‡ P < 0.05 vs Fru-NS; † P < 0.05 vs.
Fru-HS.

the groups. For clarity, Figure 2.2 depicts the progression of MAP over time only for fructosefed rats. By day 10, MAP rose significantly compared with baseline in Fru+HS rats and
remained elevated from Day 17 through the 24th day. MAP progressively declined from Day
7 to Day 24 in the Fru+HS+T group such that there was no difference in MAP among Fru+NS,
Fru+NS+T and Fru+HS+T groups by day 24; however, MAP of the Fru+HS group was
significantly greater than any of the other three groups. SBP followed the same pattern as
MAP. Glucose-fed rats in any of the groups did not display significant changes from baseline
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or among the groups in MAP at any point of time (data not shown).

Figure 2.1: Change in mean arterial pressure (MAP) Timeline (over the 3-week period for the fructose-fed
groups). Baseline MAP and delta MAP for glucose-fed groups did not change significantly over time (Table 2);
not depicted graphically for simplicity. Fru+NS, 20% fructose+0.4% NaCl; Fru+HS, 20% fructose+4% NaCl; +T,
indicates addition of 15 mg/400g BW Tempol; BW, body weight. * Values are mean ± SE; n as in Table 2. * P <
0.05 vs baseline for Fru+HS; † P < 0.05 for Fru+HS vs all other fructose-fed groups by two-way ANOVA on Day
24.

Cardiovascular parameters measured by echocardiography
The increase in MAP in the Fru+HS group was accompanied by an increase in aortic
pulse wave velocity (PWV) (803 ± 19 mm/s, P < 0.005) compared with Glu+NS (606 ± 48
mm/s), Glu+HS (645 ± 39 mm/s) or Fru+NS (700 ± 27 mm/s) groups (Figure 2.2A).
Attenuation of free radical formation decreased aortic PWV in Fru+HS+T rats (686 ± 31
mm/s, P < 0.005) compared to their non-treated counterparts (Figure 2B), while it produced
no change in PWV in other groups (Glu+NS: 681 ± 30 mm/s, Glu+HS+T: 630 ± 37 mm/s and
Fru+NS+T: 684 ± 43 mm/s).
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Figure 2.2: Aortic Pulse Wave Velocity (PWV) in (A) the four groups of rats: Glu+NS, 20% glucose+0.4% NaCl;
Glu+HS, 20% glucose+4% NaCl; Fru+NS, 20% fructose+0.4% NaCl; Fru+HS, 20% fructose+4% NaCl. (B) Aortic
pulse wave velocity in rats given either Fru+HS alone or with addition of 15 mg/400g BW Tempol (+T); BW,
body weight, Fru+HS+T. Values are mean ± SE; n as indicated per group; * P < 0.005 vs other three groups; **
P < 0.005 vs Fru+HS group.

Echocardiographic measures of systolic cardiac function revealed no overt phenotype
in rats fed fructose and high salt diet. Ejection fraction, fractional shortening, left ventricle
(LV) dimensions, and LV mass were similar across all groups (Table 2.3). Notably, only the
Fru+HS rats displayed evidence of diastolic dysfunction (Figure 2.3). Specifically, the ratio of
early (E) to late (A) transmitral filling velocities was decreased in Fru+HS rats (1.12 ± 0.03,
P < 0.005) compared with the rats on glucose (Glu+NS: 1.28 ± 0.04 and Glu+HS: 1.37 ± 0.05)
or Fru+NS rats (1.37 ± 0.08). Supplementation with the antioxidant did not change E/A in
Fru+HS rats (1.09 ± 0.07) nor in any of the other groups: Glu+NS+T (1.38 ± 0.07), Glu+HS+T
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(1.25 ± 0.06) and Fru+NS+T (1.28 ± 0.04).

Figure 2.3: Ratio of Early to Late (E/A) Transmitral Filling Velocities. In (A) the four groups of rats and
(B) rats fed fructose-high salt alone or with Tempol (+T). Group designations as in Figure 2. Values are mean
± SE; n as indicated per group; * P < 0.005 vs other three groups.

The RRI, a measure of renal vascular stiffness or impedance, was significantly
augmented in the Fru+HS group (0.60 ± 0.03, P < 0.05), compared with Glu+NS (0.45 ± 0.03),
Glu+HS (0.45 ± 0.04) or Fru+NS groups (0.47 ± 0.05) (Figure 5A). No differences were
observed among the +T-treated groups (Glu+NS+T, 0.50 ± 0.04; Glu+HS+T, 0.53 ± 0.4;
Fru+NS+T, 0.50 ± 0.02; and Fru+HS+T, 0.60 ± 0.05). Notably, the antioxidant failed to reverse
the augmented RRI in rats fed fructose and high salt diet (Figure 2.5B).
Table 2.3: Echocardiographic Parameters in Control Groups.
Glu+NS
Glu+HS
Fru+NS
Fru+HS
N
8
12
7
11
LVEF (%)
82 ± 3
78 ± 3
85 ± 2
75 ± 3
LVFS (%)
52 ± 3
48 ± 3
56 ± 3
47 ± 3
LVAWs (mm)
3.11 ± 0.15
2.92 ± 0.12
3.31 ± 0.10
2.82 ± 0.09
LVAWd (mm)
1.95 ± 0.06
1.98 ± 0.05
2.09 ± 0.09
1.85 ± 0.04
LVIDs (mm)
3.07 ± 0.32
3.22 ± 0.22
2.72 ± 0.32
2.58 ± 0.21
LVIDd (mm)
6.34 ± 0.19
6.34 ± 0.17
6.34 ± 0.27
6.58 ± 0.19
LVPWs (mm)
2.94 ± 0.18
3.17 ± 0.16
2.92 ± 0.15
2.81 ± 0.19
LVPWd (mm)
1.84 ± 0.09
1.96 ± 0.13
1.64 ± 0.14
1.84 ± 0.22
LV mass (mg)
645 ± 39
688 ± 38
663 ± 64
631 ± 33
Group definitions as in Table 1. LVEF, left ventricular ejection fraction; LVFS, left ventricular
fractional shortening; HR, heart rate; LVAWs, left ventricular end-systolic wall thickness; LVAWd,
left ventricular end-diastolic anterior all thickness; LVIDs, left ventricular end-systolic inner
diameter; LVIDd, left ventricular end-diastolic inner diameter; LVPWs, end-systolic left
ventricular posterior wall thickness; LVPWd, end-diastolic left ventricular posterior wall
thickness. Values are mean ± SE.
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Figure 2.4: Elastic Properties of the Ascending Aorta. Radial ascending aortic strain and distensibility
coefficient, respectively, in the four groups of rats (A, C) and in rats fed fructose-high salt alone or with Tempol
(B, D). Group designations as in Figure 2. Values are mean ± SE; n as indicated per group; * P < 0.05 vs other
control groups; ** P < 0.05 vs Fru+HS group.

The RRI, a measure of renal vascular stiffness or impedance, was significantly
augmented in the Fru+HS group (0.60 ± 0.03, P < 0.05), compared with Glu+NS (0.45 ± 0.03),
Glu+HS (0.45 ± 0.04) or Fru+NS groups (0.47 ± 0.05) (Figure 2.5A). No differences were
observed among the +T-treated groups (Glu+NS+T, 0.50 ± 0.04; Glu+HS+T, 0.53 ± 0.4;
Fru+NS+T, 0.50 ± 0.02; and Fru+HS+T, 0.60 ± 0.05). Notably, the antioxidant failed to reverse
the augmented RRI in rats fed fructose and high salt diet (Figure 2.5B).
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Figure 2.5: Renal Resistive Index (RRI). in (A) the four groups of rats and (B) rats fed fructose-high salt alone
or with Tempol (+T). Group designations as in Figure 2. Values are mean ± SE; n as indicated per group; * P <
0.05 vs other control groups; ** P < 0.05 vs Fru+HS group.

PRA, angiotensin II and insulin levels
High salt diet did not suppress PRA in either glucose-fed or fructose-fed rats (Table
2.4). In contrast, plasma Ang II was significantly lower in both Glu+HS and Fru+HS rats
compared with rats fed the same sugar on normal salt diet. Plasma Ang II was attenuated in
both Glu+NS+T and Fru+NS+T groups such that there were no differences among any of the
+T-treated groups. Although kidney cortical tissue Ang II tended to be higher in the +Ttreated normal salt groups vs the +T-treated high salt groups ingesting the same sugar, renal
cortical tissue Ang II levels did not significantly differ among any of the groups. Non-fasting
blood glucose values were similar among the groups (Table 2.4). Figure 2.6 shows that the
glucose:insulin ratio was significantly diminished in the Fru+HS group (P < 0.05), indicative
of insulin resistance compared with the other groups. The glucose:insulin ratio was restored
in the Fru+HS+T group to a value significantly greater than the Fru+HS group (P < 0.05).
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Table 2.4: Values for Plasma Glucose, PRA and Ang II and Renal Cortical Tissue Ang II
after 3‐Week Diet Regimen.
N

Glucose
(mg/dL)

PRA
(ng AngI per
ml/hr)

Plasma
Ang II
(fmol/ml)

Kidney Tissue
Ang II
(fmol/g)

Glu+NS

8

132 ± 2

4.7 ± 1.5

34.2 ± 4.6

1,609 ± 222

Glu+HS

12

134 ± 7

5.6 ±2.8

16.5 ± 4.2*

1,829 ± 269

Fru+NS

8

130 ± 5

5.6 ± 2.1

38.5 ± 5.8

1,667 ± 280

Fru+HS

10

137 ± 8

6.7 ± 2.8

22.2 ± 4.6‡

1,403 ± 223

Glu+NS+T

10

138 ± 6

4.9 ± 1.8

16.0 ± 2.3*

2,306 ± 396

Glu+HS+T

12

130 ± 4

5.1 ± 3.5

18.7 ± 4.3

1,376 ± 168

Fru+NS+T

9

142 ± 7

6.1 ± 3.0

25.4 ± 5.1

2,067 ± 241

Fru+HS+T

9

132 ± 3

5.3 ± 3.3

19.4 ± 3.5

1,509 ± 290

Diet

Group definitions as in Table 1. PRA, plasma renin activity; Ang II, angiotensin II. Values are
mean ± SE. * P < 0.05 vs Glu-NS; ‡ P < 0.05 vs Fru-NS.

✱✱

Figure 2.6: Glucose:insulin Ratio (nM/nM x 106) in (A) the four groups of rats and (B) rats fed fructose-high
salt alone or with Tempol (+T). Group designations as in Figure 2. Values are mean ± SE; n as indicated per
group; * P < 0.05 vs other control groups; ** P < 0.05 vs Fru+HS group.

DISCUSSION
The major findings of the present investigation support the hypothesis that fructose
and high salt feeding for as short a period as three weeks in rats results in salt sensitive
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systolic hypertension, stiffening of the ascending aorta, and diastolic left ventricular
dysfunction. This occurs at a time when the rats have insulin resistance but are not frankly
diabetic. Free radical scavenging at least partially reverses the aortic stiffening but not the
diastolic dysfunction. The vascular perturbations associated with combined fructose and
high salt intake include increased ascending aortic PWV, decreased radial ascending aortic
strain, and an impaired distensibility coefficient. The decreased E/A ratio denotes early
diastolic left ventricular dysfunction. In addition, the increase in RRI in fructose-fed, high
salt rats indicate impaired vascular compliance of the main renal artery that is not
ameliorated by 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl, suggesting a mechanistic
basis other than oxidative stress. Interestingly, although PRA is not suppressed, the
vasoactive hormone plasma Ang II is reduced after three weeks of high salt diet in both
glucose- and fructose-fed animals. Intrarenal Ang II does not appear to be affected by either
diet or antioxidant treatment.
Fructose, salt and blood pressure
The present studies confirm previous findings from our own [42] and other
laboratories [41, 62, 66] showing that consumption of fructose at levels comparable to that
ingested by the upper 20th percentile of the human population combined with high salt
intake results in elevated arterial pressure. Although the increase in arterial pressure is
modest when assessed in conscious unstressed rats by telemetry (vs tail cuff where in there
is the additional stress component of mild restraint), it is nonetheless reproducible,
significant, and sustained. Moreover, the present data indicate that the elevation in arterial
pressure is primarily due to a disproportionate rise in systolic pressure which may be more
closely related to large artery stiffness (see below). The combination of high fructose and
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high salt intake has the potential to alter arterial wall cell function and structure independent
of blood pressure [107, 108]. Hypertension, in turn, can influence vascular stiffness via
cellular and structural responses to mechanical pressure-induced wall stress [109].
Regardless of whether systolic hypertension is a cause or effect of arterial stiffness [109].
the result is a complex interplay of factors that are influenced by consumption of fructose
and high salt diet.
The observation that 4% NaCl diet does not suppress PRA in either glucose-fed or
fructose-fed animals is distinctly different than the classic suppression of PRA by high salt
diets in rats provided with normal carbohydrate diets [41, 110, 111]. Notably, earlier reports
used higher salt diets (e.g., ≥8% NaCl) that do not reflect typical human intake to inhibit PRA
and did not report plasma Ang II levels [112, 113]. Although high salt diet when ingested
with fructose suppresses plasma Ang II but not renal tissue Ang II. The persistence of high
intrarenal Ang II, which has been shown to increase proximal tubular sodium reabsorption
[62, 114]. may very well be responsible for cumulative positive sodium balance and
hypertension observed in this model [41]. Furthermore, dietary fructose augments Ang IIstimulated superoxide formation by the kidney further enhancing proximal tubular sodium
reabsorption and leading to volume-mediated hypertension [62, 111, 114]. Since antioxidant
with +T treatment does not influence either plasma or intrarenal Ang II levels, it is more
likely that its ability to decrease hypertension relates, at least in part, to its ability to decrease
oxidative stress directly on the vasculature. More definitive data measuring vascular ROS
and its products, which were beyond the scope of the present study, will be required to
address this issue directly.
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Left ventricular diastolic dysfunction
The axial heterogeneity of the aorta is well documented [115, 116]. For example, the
ratio of elastic fibers to collagen changes from 3.1:1 in the ascending aorta to 2.8:1 in the
thoracic aorta to 0.8:1 in the abdominal aorta [117]. Attenuation of the elastic properties of
the proximal ascending aorta can have profound influence on end-systolic cardiac wall stress
due to increased afterload, one of the most important factors in developing cardiac
hypertrophy,[118] hence our choice to study the ascending aorta. In addition to the
geometric properties of the left ventricle itself, aortic stiffness influences end-systolic cardiac
wall stress [119]. Although there is no evidence of left ventricular hypertrophy, our
echocardiographic studies were performed after only three weeks on the respective diets.
Nevertheless, the reduced E/A ratio in the fructose-fed high salt rats reveals diastolic
dysfunction which is the earliest indicator of hypertensive cardiac disease and precedes
frank hypertrophy or systolic dysfunction [120]. Importantly, the diastolic impairment is
significant despite the arterial pressure lowering effect of isoflurane anesthesia during the
scan. Furthermore, inhibition of oxidative stress does not ameliorate this diastolic
dysfunction despite lower arterial pressure suggesting involvement of alternative
mechanisms.
Ingestion of fructose plus high salt even, in the short-term, in the present study results
in mildly elevated non-fasting blood glucose and a depressed glucose:insulin ratio consistent
with insulin resistance similar to human pre-diabetes. Long-term studies have unequivocally
demonstrated the development of left ventricular hypertrophy in metabolic syndrome;[121]
however, even prolonged pre-diabetes provides a constellation of physiological
derangements that favor left ventricular remodeling in rats [122, 123] and humans [124]. In
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fact, fructose alone, albeit at a higher concentration (60%), causes cardiac hypertrophy in
mice after 10 weeks [125]. Moreover, direct fructation of structural proteins [107] or
alterations in sympathetic cardiac innervation [126] have been associated with diastolic
dysfunction. Thus, despite the lack of frank left ventricular hypertrophy, the presence of a
pre-diabetic state and insulin resistance is likely also contributing to the diastolic
dysfunction in the fructose plus high salt group [127].
Impairment of aortic and renal artery compliance
Diabetes[128, 129] and hypertension[130, 131] are each independently associated
with increased PWV. The increased PWV along with diminished radial ascending aortic
strain and distensibility coefficient in fructose salt-sensitive rats indicates that aortic
compliance declines early with insulin resistance prior to overt diabetes. Greater aortic
stiffness occurs with only modest (5-6 mmHg) elevations in systolic (and mean) arterial
pressure in the fructose-fed high salt rats. Increases in PWV are typically associated greater
pulse pressures. Although the change in pulse pressure was similar after three weeks of high
salt, it is noteworthy that baseline pulse pressure in the fructose-fed high salt rats tended to
be higher, albeit not statistically significant. Sympathetic innervation of the aorta is now
recognized as a factor in aortic stiffening [132], and fructose-fed high salt rats display
heightened renal sympathetic nerve activity. Renal denervation prevents the hypertension
in this and other rodent models [42, 133] and ameliorates PWV in animal [133] and human
systolic hypertension [134]. The contribution of cellular metabolic changes or ion-induced
contractility cannot be totally excluded since triglycerides and cumulative salt balance are
elevated in this model [41]. Thus, aortic stiffness is only partially dependent of blood
pressure and may also be influenced by biophysical changes in the structure and/or function
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of the arterial wall evoked by fructose plus high salt diet.
Increased oxidative stress has been implicated in decreased aortic compliance in
disease [135] as well as normal aging [136, 137]. The agent, 4-hydroxy-2,2,6,6tetramethylpiperidine-1-oxyl, is a nonselective superoxide dismutase mimetic that reduces
free radical formation and peroxynitrite formation, thereby limiting inflammation. Similar
to findings with free radical scavenging in aging mice [138], our results indicate that
attenuation of oxidative stress in fructose salt-sensitive rats rescues some aspects of elastic
properties of the aorta, restoring normal PWV and radial ascending aortic strain.
Like the aorta, renal artery compliance is reduced which is reflected by the elevated
RRI in fructose-fed high salt rats. In contrast to the ascending aorta, renal artery stiffness
does not improve after treatment with this antioxidant. Although 4-hydroxy-2,2,6,6tetramethylpiperidine-1-oxyl has been shown to decrease renal superoxide anion and
improve renal vascular resistance via a nitric oxide dependent mechanism,[111, 139] RRI
tracks more closely with systemic vascular parameters, intrinsic renal artery compliance and
pulsatility than with intrarenal vascular resistance [98]. This is not to say that this
heightened pulsatility is not transmitted distally thereby ultimately resulting in
hypertensive nephropathy and chronic kidney disease.
While the present hemodynamic measurements have been performed in conscious,
freely moving rats, ultrasonography necessitates isoflurane anesthesia. Importantly,
isoflurane anesthesia does not alter measures of arterial stiffness [140].
CONCLUSION
The rodent model used in these studies was chosen to mimic the amount of fructose
and salt ingested by the upper fifth of the western population. Notably, impaired vascular
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compliance of the proximal ascending aorta and renal artery occur after only short-term
exposure to the fructose-high salt diet when insulin resistance but not frank hyperglycemia
and only mild, but significantly elevated blood pressure occur. The loss of vascular
compliance results in transmission of the elevated pressure wave downstream and may,
thereby, predispose to hypertensive organ damage including nephrosclerosis. The presence
of left ventricular diastolic dysfunction with preserved systolic function strongly suggests
that that a diet of fructose combined with high salt exerts an independent effect on left
ventricular relaxation. Importantly, antioxidant treatment normalizes fructose-induced salt
sensitive hypertension and mitigates increase in aortic pulse wave velocity. These data,
therefore, cannot distinguish whether at aortic compliance is directly altered by reactive
oxygen species induced by the high fructose plus high salt diet or indirectly via the elevation
in arterial pressure or both. In contrast, left ventricular diastolic dysfunction and renal artery
compliance are not altered by the free radical scavenger despite the decrease in blood
pressure indicating that alternative mechanisms are responsible. Taken together, these
findings indicate that a diet high in fructose and salt may lead to subtle, possibly progressive,
pathophysiologic changes in the central cardiovascular system well before frank clinical
disease is apparent. Changes in nutritional behavior and early assessment are imperative to
foster cardiovascular health as we go forward.
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CHAPTER 3: FRUCTOSE INDUCES CHRONIC SALT‐SENSITIVITY AND RENAL
DYSFUNCTION
INTRODUCTION
Environmental and lifestyle factors such as diet have become important contributors
to the increasing prevalence of hypertension. The increase in hypertension has occurred
concurrently with the rise in consumption of fructose-sweetened products [12, 141, 142].
Likewise, sodium consumption has remained high and is directly correlated to numerous
cardiovascular and renal diseases [143, 144]. Recent research has shown that a diet high in
fructose induces a state of increased sodium retention that leads to hypertension. Onset of
this disease state occurs well before the development of metabolic syndrome or frank
diabetes mellitus [41, 42]. Adolescents and young adults, particularly those from lower
income levels, are the group consuming of the highest amounts of fructose, which is sourced
predominately through sugar-sweetened beverages [12]. Despite this disparity, there are
few studies investigating the chronic effects of these dietary regimens in youth and the
potential impact later in life.
Particularly with polygenic disorders such as hypertension, full phenotypic
manifestation does not generally occur before adulthood. The insults that shape disease
progression and extent can often be traced back to early periods of development, or
ontogeny [145]. The development of organs and physiologic systems can be attributed to
specific time points; chiefly the earliest developmental stages of these systems are marked
by the most rapid growth. During these windows of development, application of external
stimuli can exert influence that can alter physical and mechanistic organ properties. These
windows or time frames are referred to as critical developmental periods. While time frames
vary and are approximate, readjustment of central hemodynamics in response to post-natal
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growth occurs during prepuberty and sexual maturation, which occur between 4 and 6
weeks after birth [146-148]. Readjustment occurs predominately via morphogenesis,
however additional maturation of pressor governing systems such as the baroreflex and
renin-angiotensin-aldosterone-system (RAS) are simultaneously occurring [149-152].
In several preclinical models, a high salt diet in early life stages induces salt-sensitive
hypertension that may not necessarily occur when the same challenge is applied in
adulthood [153-156]. Likewise, various transient anti-hypertensive therapies applied in
adolescence attenuate the development and degree of hypertension in genetically
predisposed strains [157-159]. Notably, this effect coincides with the same critical time (49 weeks of age) periods used in salt-sensitivity programming via excess sodium loading,
further indicating the importance of these time periods in hypertension induction.
The impact of fructose programming in neonates and adolescents is less well
understood. GLUT5 is a glucose transporter that specifically transports fructose and is
considered critical to the development of fructose induced salt-sensitive hypertension [160].
It is under-expressed in neonatal intestinal tissue. After weaning there is an abrupt increase
in protein and mRNA expression, however, and these patterns can be enhanced if fructose is
provided during weaning [161, 162]. Whereas cessation of fructose feeding is marked by
restoration of fructose transport systems to control levels, the induction or maintenance of
these transport mechanisms could conceivably lead to the development of salt-sensitivity
and hypertension at a young age and beyond. Based on the observed effects of sodium
programming in youth, it is possible that exposure to fructose early in life will exert long
term effects. Thus, we hypothesize that a diet high in both fructose and salt, but not high in
fructose alone, in rats aged 5 – 7 weeks will lead to salt-sensitive hypertension in adult life.

38
MATERIALS AND METHODS
Animals
Since previous reports were almost exclusively performed in male rats, our studies
were performed in male rats to permit assessment of the impact of fructose in the context of
existing studies. Male Sprague Dawley rats (Envigo Sprague Dawley, Shelby, MI) were
housed under controlled conditions (21–23°C; 12-hr light/ dark cycles, lighting period 6 AM
to 6 PM). Complete care provided to rats was in accordance with the principles of the
National Institutes of Health Guide for the Care and Use of Laboratory Animals. All procedures
and protocols were approved by the Wayne State University Institutional Animal Care and
Use Committee (Protocol #19-03-1001).
Dietary regimen
Upon arrival, rats were acclimated in standard polyurethane caging and were
permitted ad libitum access to water and standard rat chow for a minimum of 48 hours prior
to enrollment in the experimental protocols. At the age of 4-5 weeks (body weight ~125 g),
rats underwent placement of a hemodynamic telemetry transmitters and recovered in single
housing for 3-5 days. Following recovery, rats were placed into metabolic housing units
(Tecniplast USA, West Chester, PA) and randomly fed chow containing either 20% fructose
or 20% glucose with 0.4% sodium. These diets were provided ad libitum for 5-7 days to
permit baseline hemodynamic recordings. Then, the rats were formally entered into the
phases of the protocol (Figure 3.1).
Phase I (Days 0 – 22±2): Rats were assigned to chow containing 20% glucose and
0.4% sodium group (glucose low sodium - GLS; ModTest Diet® 5755 – 5WZZ; n = 10); 20%
fructose and 0.4% sodium (fructose low sodium - FLS; ModTest Diet® 5755 - 5W3Y, n = 9),
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Figure 3.1: Timeline of Experimental Protocols, Division of Phases, and Allotment of Dietary Regimens
and Groups.
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or 20% fructose and 4.0% sodium (fructose high sodium - FHS; ModTest Diet® 5755 – 5WZ8;
n = 18) for 3 weeks. Rats were pair-fed indexed to overall caloric intake due to account for
differences in energy profiles (kcal/g) among the dietary formulations. Water provision in
all groups remained ad libitum throughout the study.
Phase II (Days 23 – 44±2): The rats were returned to singly housed, polyurethane
cages in which food and water were provided ad libitum. All rats on the GLS and FLS diets
and 50% of the rats on the FHS diet were placed on the GLS diet. The remainder of the FHS
rats remained on the FHS diet.
Phase III (Days 45 – 66±2): Rats were returned to metabolic housing units after three
weeks and were permitted a three-day acclimation period. Rats fed fructose in Phase I were
subjected to a high salt challenge with 20% glucose and 4.0% sodium (glucose high sodium
- GHS; ModTest Diet® 5755 – 5WOW). As a control, the GLS group from Phase I remained on
GLS diet. This resulted in four overall groups: 1) GLS-GLS, 2) FLS-GHS, 3) FHS-GHS, and 4)
FHS-FHS. This regimen was continued for an additional three weeks at which time terminal
studies were conducted.
Surgical procedures
Hemodynamic Telemetry Transmitter Placement. All surgical procedures were
conducted under intraperitoneal ketamine (80 mg/kg; Mylan Institutional, LLC Rockford, IL)
and AnaSed/xylazine (10 mg/kg; Akorn Animal Health, Inc., Lake Forest, IL) anesthesia and
subcutaneous administration of buprenorphine SR (0.3 mg/kg) for analgesia. For
hemodynamic telemetry unit placement, an inguinal incision was made, and the right
femoral artery was exposed. Permanent ligation of the distal artery was placed using 3-0 silk
suture while a proximal segment of the vessel was temporarily occluded using a vascular
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clamp. A small arterial incision was made and the gel-filled catheter of the hemodynamic
transmitter (HDS-10, Data Sciences International, MN) was inserted into the vessel using a
21-gauge needle as a guide. The vascular clamp was then removed and the catheter advanced
into the abdominal aorta. The transmitter body was subcutaneously tunneled dorsally to the
right flank and the incision was closed using surgical staples.
Vascular Catheter Placement. At the end of Phase III, catheters were placed into the
left carotid artery and external jugular vein using anesthetic and analgesic regimen above as
previously performed in our laboratory [42, 163]. Catheters were anchored using 3-0 silk
suture, tunneled subcutaneously, and exteriorized between the scapulae. All incisions were
closed using 4-0 Prolene suture (Ethicon, Johnson & Johnson, New Brunswick, NJ). The
catheters were filled with heparinized saline (1000 units/mL) and secured. The rats were
then permitted to recover in individual standard cages.
Analytical measurements and calculations
Telemetry. Acquisition of hemodynamic data was conducted using Ponemah software
(Data Sciences International, MN). Measurement of systolic blood pressure (SBP), diastolic
blood pressure (DBP), mean arterial pressure (MAP), and heart rate (HR) were sampled for
10 seconds every 4 minutes at a sampling rate of 500 samples/second. Pulse pressure (PP)
was calculated separately using these values. Baseline measurements were averaged over
three days following a three-day cage acclimation. Sampling was performed at this rate
continuously throughout each study phase within metabolic cages.
Metabolic Assessment. Water intake, chow consumption, and urine volume were
measured gravimetrically. Urinary sodium and potassium were measured via flame
photometry using an internal lithium standard (Cole Parmer Instruments, Verner Hill, IL).
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Transcutaneous Assessment of Renal Function. Glomerular filtration rate (GFR) was
assessed at the end of each phase (Figure 3.1) using venous bolus injections of fluoresceinisothiocyanate-(FITC)-sinistrin as described by Schock-Kusch et al [164]. Rats were briefly
anesthetized with isoflurane and a small adhesive patch with an LED-emitting optical
transducer (Mannheim Pharma and Diagnostics GmbH, Mannheim, Germany) was placed on
a shaved region on the dorsal aspect of the thorax. Baseline measurements were recorded
for 3-5 minutes, thereafter a single bolus injection of FITC-sinistrin, 6 mg/100 g BW
(Fresenius-Kabi, Linz, Austria) was administered via tail vein (Phases I and II) or venous
catheter (Phase III). Rats were recovered in singly housed polyurethane cages and
measurements were recorded for 2 hr. FITC-sinistrin disappearance kinetics were analyzed
via a 3-compartment approach using MB Studio software (Mannheim Pharma and
Diagnostics GmbH, Mannheim, Germany). GFR was calculated using the following formula:
[22]

GFR[ml/min/100g BW] =

31.26[ml/100gBW]
t1/2(FITC−sinistrin)[min]

Terminal Procedures and Hormonal Assessment. Following the GFR assessment after
Phase III, the rats were permitted a 6-8 hour recovery period with no access to food before
terminal harvest. Blood was collected from conscious rats via the carotid arterial catheter
into pre-chilled tubes for hormonal analysis. Fasting glucose levels were determined using a
One-Touch Ultra glucose monitor (LifeScan, Inc., Malpitas, CA). For plasma renin activity
(PRA) assay, 1 mL of blood was collected into a tube containing 50 μL sodium
ethylenediaminetetraacetic acid (EDTA). Blood (2 ml) was collected into a separate tube
containing 120 μL of 500 mM sodium EDTA, 125 mM phenanthroline, 1 mM
phenylmethanesulfonyl fluoride, 20 mM pepstatin, 1 mM enalapril and 10X phosphatase
inhibitor cocktail for insulin assessment. Once collected, blood was immediately centrifuged
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at 3000 rpm for 4 minutes at 4°C. Plasma was stored at -70°C until assayed.
Rats were then euthanized with sodium pentobarbital (120 mg/kg, iv). Kidneys were
harvested, kept at 0°C in saline, and weighed. A segment of renal cortex was excised and
stored at -70°C. A slice of kidney tissue was placed into formalin for 48 hr and paraffin
embedded for histological analysis for future studies.
Statistical analysis. Between-group differences in the pattern of change over the study
design were tested in a repeated-measure ANOVA framework, interpreting multivariate
statistics as a profile analysis of longitudinal change. Consistent with the experimental
design, hypothesis tests were conducted for Phase 1 and Phase 3 separately, without need
for multiple comparison correction between phases in variable timeline assessments. Based
on initial visual evaluation, the trajectories of daily change appeared non-linear, and an
analytic approach was taken in which hypotheses were tested separately for Weeks 1 – 3 of
each Phase. Type I error rate was controlled across the multiple tests by week with a
Bonferroni correction for three comparisons (α’ = 0.02). Missing data points in daily
measurements were adjusted for by substituting overall phase group means. Group sizes
may among variables due to anatomic and or technical issues that precluded assessments of
some measurements.
RESULTS
Acute and chronic hemodynamic effects of diet in adolescence. The addition of high salt
to fructose fed rats led to a progressive increase in mean arterial pressure that was
significantly elevated after four days (Figure 3.2). This increase was maintained for an
additional two weeks before becoming statistically comparable to other groups at the end of
Phase I. Whereas groups did not differ in Phase I final MAP levels, the overall change between
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final and baseline values of Phase I in FHS groups was statistically greater than that of other
groups (p<0.01). Throughout Phases II and III, FHS feeding led to a continuously increasing
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MAP, though this was not significant throughout the remainder of the study (Table 3.1).

Figure 3.2: Timeline of Daily Mean Arterial Pressure. Measurements calculated as the average of 24 hour
daily intervals. Measurements acquired from a catheter implanted into the abdominal aorta. Values are
indicated as mean ± SE, N as indicated per group; *p<0.05 FLS-GHS vs. GLS-GLS.
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In phase III, mean arterial pressure significantly increased over the first week (p <
0.001) and the pattern of change differed among groups (P = 0.001): FHS-FHS and FLS-GHS
demonstrated moderate increase, as compared to a relatively smaller increase in FHS-GHS,
and stability of GLS-GLS. With one-way ANOVA to examine the specific group differences at
Day 1 and Day 7, groups were overall equivalent at the start of Phase 3 (P = 0.11) but within
a week group differences emerged (P = 0.001) following apparent elevation in FLS-GHS and
FHS-FHS. Subsequent change over week 2 was also different among groups (P = 0.015) and
by Day 14, FLS-GHS stabilized to average levels consistent with FHS-FHS (P = 0.79) and FHSGHS (P = 0.60).
Table 3.1: Study‐wide Changes in Hemodynamics.

N

STUDY
Δ MAP
(MMHG)

STUDY
Δ SBP
(MMHG)

STUDY
Δ DBP
(MMHG)

STUDY
Δ HR
(BPM)

STUDY
Δ PP
(MMHG)

7

10.0±1.0

11±2.2

11±1.2

-92±11

2.4±1.5

FLS‐GHS

8

15±0.9*

18±0.9*

14±1.3

-103±18

4.2±1.6

FHS‐GHS

8

15±1.4*

18±1.7*

13±1.7

-105±6

4.2±2.0

DIETARY
REGIMEN
GLS‐GLS

FHS‐FHS

8
16±2.0**
4.6±1.4
19±2.3**
14±1.9
-89±14
Calculated as the difference between measurements taken at the end of Phase III and the baseline
measurements taken at the beginning of Phase I. Values are indicated as mean ± SE, N as indicated per group;
*P <0.05 vs. GLS-GLS controls. **P <0.01 vs. GLS-GLS controls.

Study-wide analysis (Table 3.1) evaluating the overall change in hemodynamic
parameters throughout the entirety of the study indicated comparable increases between
FLS-GHS and FHS-GHS groups that were significantly elevated above GLS-GLS controls
(P<0.05). The increases in FHS-FHS controls were elevated above this when compared to
controls (P<0.01). Overall study changes in SBP followed similar trends as MAP, but DBP and
heart rate did not. While the change in DBP was not significant it increased sufficiently to
prevent any statistically observable differences in pulse pressure.
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Acute and chronic metabolic profiles of fructose and high salt programming during
adolescence. Except during the initial baseline recordings, all rats in metabolic cages in
Phases I and III were placed on a pair feeding paradigm. Chow consumption was assessed
daily, and the amount provided was determined by caloric consumption, rather than direct
gravimetric assessment. This protocol design was implemented as a more accurate
correction to limit differences in total nutritional consumption due to the varying energy
profiles (caloric content) of each type of chow. Statistical differences between caloric intake
were observable initially following dietary changes to high salt feeds in both glucose and
fructose groups in both Phases I and III, but these gradually normalized among groups. High
Na+ intake was accompanied by increased fluid intake and urine excretion, both of which
reached a maximum by the end of week 2 in Phases I and III (Table 3.2).
As defined in Methods, high and low salt feeds were comprised of 4.0% Na+ and 0.4%
Na+, respectively. Consistent with a pair feeding strategy, low salt fed rats consumed
approximately 10% of the amount of sodium consumed by high salt fed rats (Table 3.3). This
increase in dietary sodium intake was accompanied by increases in both urine production
and Na+ excretion. Albeit, sodium excretion was significantly increased compared to low salt
diets, it was insufficient in maintaining a neutral bodily sodium balance. Net (Figure 3.3A&B)
and cumulative (Figure 3.3C&D) Na+ balances are depicted in Figure 3.3. Phase I net Na+
balances changed over week 1 (P < 0.001) and groups differed in the pattern of change (P <
0.001): FHS-FHS and FLS-GHS both show faster increase over the initial 7 days of Phase I as
compared to stable low levels of GLS-GLS and stable high levels of FHS-GHS. Over this period,
groups differed on average (P< 0.001): GLS-GLS had a lower net Na+ balance as compared
with all other groups (all P < 0.001), and FHS-GHS greater than FHS-FHS (P = 0.04). Between
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group differences were only evident in week 1, and net Na+ did not change over week 2 (P =
0.36) or week 3 (P = 0.09). GLS-GLS remained significantly lower than all other groups over
week 2 (p < 0.001) and week 3 (p < 0.001), however all other group comparisons were not
statistically significant.
Table 3.2: Daily Metabolic Measurements.

Recorded at 5 PM each day. Caloric intake calculated using caloric profiles of 3.98 kcal/g and 3.61 kcal/g for
low salt and high salt feed, respectively. Values are indicated as mean ± SE, N as indicated per group; *p<0.05
vs. GLS-GLS; †‐p<0.05 vs. FHS-FHS.
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Table 3.3: Ionic Consumption and Excretion.

Measurements obtained via flame photometry analysis of urine samples collected daily. Values are indicated
as mean ± SE, N as indicated per group; *p<0.05 vs. GLS-GLS controls; †‐p<0.05 vs. FHS-FHS controls.
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High and low salt feeds were comprised of 4.0% Na+ and 0.4% Na+, respectively.
Consistent with a pair feeding strategy, low salt fed rats consumed approximately 10% of
the amount of Na+ consumed by high salt fed rats (Table 3.3). This increase in dietary sodium
intake was accompanied by increases in both urine production and sodium excretion.
Although sodium excretion was significantly increased compared to low salt diets, it was
insufficient in maintaining a neutral bodily Na+ balance. Balances are expressed in terms of
net and cumulative Na+ balances in Figure 3.3.
Observed net Na+ balance in FHS rats in Phase I significantly increased from baseline
to day 8 (p< 0.001), continued to change across week 2 (P= 0.003), but normalized by week
3 (P = 0.25). This trend was reflected by a continuously and significantly increasing
cumulative balance throughout weeks 1-3 following baseline (P < 0.01). Phase III net Na+
balances changed over week 1 (p < 0.001) and groups differed in the pattern of change (p <
0.001): FHS-GHS and FLS-GHS both show faster increase over 7 days as compared to stable
low levels of GLS-GLS and stable high levels of FHS-FHS. Over this period, groups differed on
average (p < 0.001): GLS-GLS had a lower net Na+ balance as compared to all other groups
(all p < 0.001), and FHS-GHS greater than FHS-FHS (p = 0.04). Between group differences
were only evident in week 1, and net Na+ did not change over week 2 (p = 0.36) or week 3 (p
= 0.09). GLS-GLS remained significantly lower than all other groups over week 2 (p < 0.001)
and week 3 (p < 0.001), however all other group comparisons were not statistically
significant.
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Figure 3.3: Bodily Sodium Balance. Measurements obtained via flame photometry analysis of urine samples
collected daily. Values are indicated as mean ± SE, N as indicated per group. A.) Phase I net sodium balances *p<0.05 vs. GLS-GLS controls. B.) Phase I Cumulative Sodium Balance - *p<0.05 for rate and absolute values vs
GLS. C.) Phase III Net Sodium Balances - *p<0.05 FHS-GHS and FHS-FHS vs. GLS-GLS controls, Ωp<0.05 FLS-GHS
vs. GLS-GLS. Phase I Cumulative Sodium Balance - *p<0.05 for rate and absolute values vs GLS. D.) Phase III
Cumulative Sodium Balance - *p<0.05 for absolute values of FHS-GHS vs. FHS-FHS.

Cumulative sodium balance increased all but GLS-GLS groups during Phase III: (P<
0.001), week 1-3 respectively. Groups differed in the magnitude of change across all weeks
(P < 0.001). The group and day interaction was driven by GLS-GLS remaining stable while all
other groups increased. A pattern of between-group differences emerged over the three
weeks (P < 0.001), with all groups equivalent at week 1 and week 2 (except GLS-GLS, P <
0.01) and FHS-GHS observed with higher cumulative sodium balance than FHS-FHS (P <
0.03) by week 3. This effect by the last week appears to be due to a slight elevation at Day 1
and not necessarily a meaningfully different rate of increase; although the group difference
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to start was small and not statistically significant, the meaningful effect in FHS-GHS emerged
over time as a compounding effect in cumulative Na+ balance.
Table 3.4: Metabolic, Renal, and Endocrine Measurements.
FINAL
BODY
WEIGHT
(G)
380±27

LEFT
KIDNEY
WEIGHT
(G/KG)
3.3±0.3

RIGHT
KIDNEY
WEIGHT
(G/KG)
3.2±0.2

FASTING
GLUCOSE
128±13

G:I RATIO
(X106)
64.7±6.4

PRA (NG
ANG I/ML/
HR)
1.82±0.20

DIETARY
REGIMEN
GLS‐GLS

N
9

INITIAL
WEIGHT
(G)
125±4

FLS‐GHS

9

132±4

346.7±30

3.7±0.4*

3.5±0.4*

129±24

74.6±12.6*

0.66±0.12**

FHS‐GHS

8

128±3

362.2±33

3.5±0.3

3.4±0.2

126±14

31.6±1.9

1.35±0.28

FHS‐FHS

127±5
43.0±8.3
1.09±0.29*
9
365.8±36 3.7±0.3* 3.7±0.2*
118±11
Assay values conducted using blood samples collected through an intra-arterial line extracted under conscious
conditions. Rats were fasted for a minimum of 6 hours prior to collection. Values are indicated as mean ± SE, N
as indicated per group; *p<0.05 vs. GLS-GLS controls, **p<0.01 vs. GLS-GLS controls Due to technical
complications, G:I (Glucose:Insulin) ratio N values differ and are as follows: GLS-GLS -5 , FLS-GHS - 6, FHS-GHS
- 7, FHS-FHS - 7.

Chronic effects on metabolism, endocrine systems, and renal function. Table 3.5
represents primary findings from terminal procedures. One-way ANOVA of final body
weights did not find significant variance amongst groups, although the FLS-GHS group
differed significantly from GLS-GLS controls. Likewise, there were no significant differences
between right and left kidney weights. However, normalization to body weight found
increased weight of both kidneys in FLS-GHS and FHS-FHS.
No significant differences in fasting plasma glucose levels were found among groups,
and these levels did not vary from vendor specifications for Envigo® bred Sprague-Dawley
rats. Plasma insulin levels indicated a reduced level of fasting insulin compared to other
groups, but this was insufficient in producing any statistical trend when analyzed by ANOVA
(data not shown). A glucose:insulin ratio was chosen as a measure of insulin sensitivity given
our inability to perform overnight fasting for HOMA measurements of insulin resistance (due
to IACUC restrictions) and the relevance of the glucose:insulin ratio to prior studies
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conducted by our laboratory [42, 163]. The reduced insulin levels in FLS-GHS rats drove the
significance in this group upon ANOVA analysis of G:I ratio. All other groups remained
statistically similar. This decline was associated with a reduction in weight and caloric
consumption in this group at the time of conversion to a high salt diet in Phase III.
Assessment of glomerular filtration rate (Figure 3.4) found no difference among
groups at the end of Phase I and Phase II, with little change within each group between
phases. GLS-GLS fed rats showed no significant differences over time. Conversely, FHS-FHS
groups experienced a significant decline in GFR. Phase III was particularly characterized by
this reduction in the FHS-FHS group. Reductions in GFR in this group were significant when
compared to GLS-GLS in Phase I and Phase III, as well as in pairwise analysis of FHS-FHS
changes over time. Whereas FHS-GHS did not significantly decline in Phase III compared to
GLS-GLS rats, groupwise changes over time were significant. FLS-GHS fed rats followed a
similar trend over time, but this did not achieve statistical significance. The reduction in GFR
in the FLS-GHS group, chiefly between Phases II and III, is considered a product of
tubuloglomerular feedback in response to the recent high salt challenge and increasing
arterial pressure. In contrast, functional reductions in FHS-GHS and FHS-FHS groups are
likely caused by vascular or morphologic changes and warrant further investigation.
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Figure 3.4: Assessment of Glomerular Filtration Rate. Measurements obtained at the end of each phase.
Phase I measurements were obtained after randomization into final group assignments, permitting assessment
of all 4 groups. N values per phase are demonstrated graphically. Values are indicated as mean ± SE; *p<0.05
vs. GLS-GLS controls, Ωp<0.05 vs initial Phase I measurements for the same group assessed via two-way ANOVA.

DISCUSSION
The present study provides support that high dietary fructose and sodium
consumption patterns can induce hypertension in adolescence with chronic effects
manifesting in later life when challenged only with high salt intake. The physiologic changes

54
that occur during these developmental periods have lasting effects that can render the body
susceptible to hypertensive stimuli later in life. Hypertension induction in adult rat models
via high salt loading alone would require prolonged periods of feeding, making the model
unappealing due to economic and logistical constraints. These time periods would extend
beyond the relatively brief periods critical to ontogenetic programming of hypertension.
Indeed, the induction of hypertension in early life using high salt in rat models cannot, to our
knowledge, be accomplished without additional manipulations that render the body more
susceptible to the influence of sodium. Such manipulations include surgical deformation,
either breeding or direct induction of genetic predispositions, chemical treatment (i.e.
deoxycorticosterone-acetate), or severe metabolic disturbances [165-170]. Diets rich in
fructose and sodium are immersed into western culture throughout all periods of life. The
propensity for higher daily ingestion of fructose and salt in adolescents and young adults
provides a strong basis for rigorous evaluation of the impact on subsequent cardiovascular
and renal function and the relevance of this study.
The increases in arterial pressure in this model of fructose-induced salt-sensitive
hypertension have been observed in several other studies [41, 42, 66]. These studies
however used methods of blood pressure measurements that made discernment of
individual contributions of each hemodynamic component difficult. In this study, chronic
telemetry-based recording enabled a well-defined examination of BP changes over time.
Analysis of change throughout the entire study unveiled significant increases in MAP in FLSGHS, FHS-GHS, and FHS-FHS groups. Significant increases in systolic blood pressure were
observed with no significant change in DBP occurred, indicating the increase in MAP was
driven by systolic mechanisms.
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The greatest increases in BP throughout the study were observed in the chronically
fed FHS group, but values were only significantly elevated in Phase I and then proceeded to
gradually increase throughout the remainder of the study. Significant increases in MAP that
occur in any group throughout the study consistently coincide with the dietary addition of
high salt. FHS-GHS groups experienced a significant increase in Phase I with a secondary
increase when challenged with the addition of high salt in Phase III. BP patterns in the FLSGHS group followed those of the GLS-GLS controls until Phase III, which was characterized
by the most significant increase among all groups when given high salt. With regards to
hemodynamic changes, the dietary addition of fructose during weeks 5 to 7 is as important
in the development of susceptibility to salt sensitive hypertension later in life as sodium is
itself.
Prior in vivo and ex vivo studies in adult rats have shown that both short term and
chronic feeding, or acute perfusion of fructose increases activity and expression of fructose,
sodium, and chloride transport systems within across the intestinal and renal epithelium.
The osmotic gradient that develops in the intestine is important for absorption and initial
increases of extracellular volume while the reabsorption mechanisms within the kidney
serve to maintain and even potentiate this effect [40, 60, 160, 171-173]. Rats fed a FHS (both
FHS-FHS and FHS-GHS groups) diet in Phase I had a significant increase in net sodium
balance during Phase III, calculated as the difference between sodium consumption and
urinary excretion. This was accompanied by an increase in net fluid balance, indicating
increased fluid retention.
These trends follow those of similar studies using DOCA to induce salt-sensitive
hypertension. Treatments initiated during early critical developmental periods elicited
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robust increases in extracellular volume and arterial pressure that were not observable
when treatments were initiated in adulthood [174]. Chronic increases in extracellular
volume cannot perpetually drive increasing arterial pressure, however, as this would
ultimately prove fatal. Pressure natriuresis in each high salt fed group was sufficient to
prevent further increases in arterial pressure but unable to restore them to normotensive
levels, potentially indicating baroreceptor resetting at central and renal levels.
The maintenance in post-pubertal arterial pressure indicates additional mechanisms
in place, many of which have been investigated in other studies. Changes in autonomic
activity that can modulate physiologic function both locally and regionally have been
implicated with high salt, with and without the addition of dietary fructose [175]. This may
serve to increase total peripheral resistance, cardiac function, or directly influence the RAS
[176]. Indeed, renal sympathetic activity is increased in adult rats fed a fructose and high salt
diet and stimulates renin secretion [42]. Thus, suppression of PRA by increased blood
pressure and extracellular volume may be counteracted by enhanced sympathetic input to
the kidney. Consistent with such a mechanism, the FLS-GHS group had the greatest extent of
renin suppression (indicated by reduced PRA). In contrast, early exposure to FHS in the FHSGHS and the FHS-FHS groups prevented suppression of PRA later in life. . Contrastingly, no
reduction in PRA in FHS-GHS groups compared to GLS-GLS controls was observed which
likely played a consequential role in the increased sodium reabsorption in Phase III and the
elevated arterial pressure. Altered renal sympathetic activity and resetting renal
autoregulatory mechanisms may be implicated in this but were not the focus the study [177179]. Additionally, our laboratory has shown that reactive oxygen species has are also
implicated in fructose and high salt diets. Oxidative stress can further induce vaso-
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dysfunction, tubule sodium reabsorption, and renin secretion [180-183].
Perspectives
These mechanisms provide insight into the observed effects of the FHS-FHS and FHSGHS groups in Phase III, all of which were likely exaggerated by ontogenetic programming
[184]. Previous studies have demonstrated that high salt or even glucose combined with high
salt does not increase net sodium balance in and of itself, nor does it have any significant
impact on arterial pressure [41, 42, 163]. The present study found that a priming period of
solely fructose feeding was necessary to promote a state of salt-sensitivity capable of
eliciting increases in blood pressure following high salt challenge in the absence of fructose
later in life. While alternative mechanisms acting to increase blood pressure such as
increased sympathetic activity – regional or peripheral – or vascular dysfunction cannot be
disregarded, the central role of the kidney in this model cannot be understated. Renal
reabsorption of sodium plays an essential role in the development of hypertension in
adolescence and the prolonged salt-sensitivity well into adulthood, despite the restoration
of non-pressor inducing diets.
In light of research into protein and mRNA expression patterns of the relative sodium
and fructose transport systems during fructose feeding, this period likely reflects a
developmental, transport aggregational state. Singh et al. showed that within two weeks of
fructose feeding, mRNA and protein abundance of intestinal transporters such as PAT1,
GLUT5, NHE3 substantially increased and remained elevated with prolonged fructose
feeding [160]. Similar patterns are observable within the kidney through post-translational
and post-transcriptional mechanisms [172]. As discussed above, GLUT5 expression can be
manipulated if fructose is provided to weanling rats, and this programming would likely
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serve to amplify the already dramatic expression increases occurring in the presence of
fructose. To our knowledge, expression of these transport systems has not been investigated
following the cessation of fructose feeding. The extent and time length these transporters
remain expressed would provide pathologic insights into the robust salt-sensitivity response
to high salt challenge later in life, as observed in the FLS-GHS group.
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CHAPTER 4: ACUTE AND CHRONIC CARDIO‐RENAL CONSEQUENCES TO FRUCTOSE‐
INDUCED SALT‐SENSITIVE HYPERTENSION INDUCED IN ADOLESCENCE
INTRODUCTION
The prevalence of hypertension has been increasing in the United States both
independently and concurrently with the rise of diabetes throughout the past several
decades. Elevated fructose consumption has been implicated in metabolic disorders and
subsequent cardiovascular morbidity [12, 13, 32]. In most pre-clinical models, high levels often exceeding 60% of daily caloric intake - of fructose consumption elicit hypertension and
cardiovascular dysfunction, and implicate insulin signaling as the pathogenic mechanism
[31, 32]. Ingestion of 20% fructose in drinking water together with a high salt diet, levels
comparable to the diet ingested by the upper quintile in humans, results in sodium and fluid
retention in rats, leading to a hypertensive state prior to development of frank metabolic
syndrome or diabetes [41, 42].
Adolescence is marked by the continuous development and growth of physiologic
systems. Particularly in earlier stages of life, various systems undergo substantial
developmental changes and are susceptible to modulation by external stimuli. While there
are several studies on the effect of fructose consumption on cardiorenal systems in adults,
little is understood regarding the impact of diets rich in fructose alone on development
during adolescence [77]. Notably, western diets use high fructose corn syrup extensively as
a sweetener and are also high in sodium content [13]. In this regard the largest consumers
of fructose are adolescents and young adults – particularly those of low-income families.
Sugar sweetened beverages represent the main source of fructose intake and in young adults
this accounts for as high as 20% of daily energy consumption [17, 185].
Since preclinical studies indicate that a diet high in both fructose and salt results in
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hypertension, aortic stiffness, and early diastolic dysfunction, the question arises whether
ingestion of high fructose and salt during a critical early life period predisposes to saltsensitive hypertension and cardiovascular dysfunction in later life [41, 42, 66, 163, 186].
Particularly with cardiovascular development, rat models have shown that interventions
during critical time periods of ontogeny known as developmental windows, may alter
susceptibility to hypertension later in life and induce substantial physiologic and anatomical
changes that render the animal prone to subsequent cardiovascular co-morbidities [187].
Currently, the predominant insights regarding how post-gestational insults affect arterial
pressure development can be garnered from studies using genetically hypertensive strains
rat (dahl salt-sensitive and spontaneously hypertensive, namely) to investigate the effects of
environmental and genetic factors and their impact on disease progression [187]. In cases of
salt-sensitivity, severe salt-deprivation during critical developmental periods (4-9 weeks)
blunts hypertensive development while increased sodium intake accentuates it [188-190].
Salt-sensitivity can be assessed clinically using a variety of protocols; however, it can
be defined generally as a 5-10% change in arterial pressure following a change in dietary
sodium intake [191, 192]. We recently tested the hypothesis that a 20% fructose and 4%
sodium diet provided early in life rats renders the animal prone to salt-sensitive
hypertension later in life (Chapter 3). The purpose of the present study was to investigate
the longitudinal functional alterations to function to provide mechanistic insights into
disease progression. We hypothesized that rats consuming a diet with 20% fructose and with
or without 4% sodium during weeks five to eight (inclusive) will develop elevated blood
pressure, reduced arterial compliance, and diastolic left ventricular dysfunction in
adulthood when challenged with high dietary sodium alone.
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MATERIALS AND METHODS
All animal procedures and protocols were approved by the Wayne State University
Institutional Animal Care and Use Committee (Protocol #19-03-1001). Animal care and
experimentation was conducted in accordance with the guidelines and principles of National
Institutes of Health Guide for the Care and Use of Laboratory Animals. Male Sprague Dawley
rats (Envigo Sprague Dawley, Shelby, MI) were housed under controlled conditions (21–
23°C; 12 hr light and 12 hr dark cycles, lighting period beginning at 6 AM).
Dietary regimen
Upon arrival rats were permitted to acclimate for at least 48 hours and provided
standard lab chow and water, ad libitum. As depicted in Figure 1, when rats reached ~4.5
weeks of age and ~125 grams, a hemodynamic transmitter was implanted and the animal
was permitted to recover in individual standard polyurethane caging. One week later, rats
were placed into metabolic housing units (Tecniplast USA, West Chester, PA) and provided
milled feed containing either 20% glucose and 0.4% Na+ (glucose low salt – GLS, ModTest
Diet® 5755 – 5WZZ) or 20% fructose and 0.4% Na+ (fructose low salt - FLS, ModTest Diet®
5755 - 5W3Y). Rats were permitted a 3-day acclimation period followed by a 3-day baseline
period where food and water were provided ad libitum. GLS rats (n = 9) were continued on
the same diet. Rats receiving FLS chow were then randomly assigned into continue on FLS
(n= 9) or 20% fructose and 4.0% Na+ (fructose high salt – FHS, ModTest Diet® 5755 – 5WZ8;
n = 18). At this time, a pair feeding paradigm was initiated among groups to achieve equal
caloric intake among the groups on a day-to-day basis. Water continued to be provided ad
libitum. The diets were maintained for three weeks (Fig 4.1, weeks 2 to 4) during which fluid
and urine outputs were assessed daily. The rats were then returned to standard individual
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housing units (Figure 4.1, weeks 5 to 7). Rats on GLS feed were maintained on this diet for
the remainder of the study. All rats on FLS feed were then placed on GLS chow. The rats on
FHS chow were then further randomly assigned to receive GLS feeding (n = 9) or to continue
the FHS diet (n = 10). The rats on FHS during Phase 2 remained on FHS through to the end
of the study.
After 3 weeks, rats were returned to a metabolic cages and permitted to acclimate to
the change in caging for three days. FLS and FHS fed rats that had been shifted to a GLS feed
were then subjected to a high salt challenge without fructose for the remainder of the
protocol using a 20% glucose and 4.0% Na+ chow (glucose high salt – GHS, ModTest Diet®
5755 – 5WOW). This produced four groups characterized by their dietary regimens in the
early and late phases – Phase 1 and Phase 3, respectively (Figure 4.1) - of the protocol: a)
GLS-GLS, b) FLS-GHS, c) FHS-GHS, and d) FHS-FHS. Rats were maintained on these diets for
an additional 3 weeks; thereafter terminal studies were performed.
Surgical procedures
All surgical procedures were conducted under intraperitoneal ketamine (80 mg/kg;
Mylan Institutional, LLC Rockford, IL) and xylazine (10 mg/kg; Akorn Animal Health, Inc.,
Lake Forest, IL) anesthesia and subcutaneous administration of buprenorphine SR (0.3
mg/kg) for analgesia.
Hemodynamic Transmitter Placement. Following right femoral artery isolation, a
small arterial incision was made, and the gel-filled catheter of the hemodynamic transmitter
(HDS-10, Data Sciences International, MN) was inserted into the vessel and advanced into
the abdominal aorta. The catheter was then anchored in place within the femoral artery
using 3-0 silk suture (Ethicon, Johnson & Johnson, New Brunswick, NJ) and the transmitter
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body was subcutaneously tunneled to the right flank. Subcutaneous adipose tissue was

reapproximated around the surgical sight and the incision was closed using surgical staples.

Figure 4.1: Timeline of Experimental Protocols, Division of Phases, and Allotment of Dietary Regimens
and Groups. *Note: Figure adapted from Figure 3.1.

AGE
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Vascular Catheter Placement. At the end of Phase III, catheters were placed into the
left carotid artery and external jugular vein using the anesthetic and analgesic regimen above
and as previously performed in our laboratory [42, 163]. Catheters were anchored using 30 silk suture and tunneled subcutaneously behind the scapulae for exteriorization. All
incisions were closed using 4-0 Prolene suture (Ethicon, Johnson & Johnson, New Brunswick,
NJ). The catheters were then filled with heparinized saline (1000 units/mL) and secured.
The rats were then permitted to recover in individually housed polyurethane cages.
Ultrasonography
At the end of Phases I and III, rats were anesthetized in an induction chamber using
3% isoflurane and transferred to a pre-heated electronic ECG platform where 1-1.5%
isoflurane was delivered via nosecone to maintain a sufficient plane of anesthesia. Fur from
the chest and abdominal area was removed using an electric shaver followed by application
of depilatory cream (Pharmaceutical Innovations, Newark, NJ). Electrode gel was placed on
each of the ECG strips and the rat’s limbs were situated in place using tape. Body temperature
was measured via a rectal probe and contact gel preheated to 37°C was applied before
performing echocardiography according to standard methods [103, 104].
Image acquisition was performed using the Vevo3100 Imaging system and MX250S
transducer (Fujifilm Visualsonics, Inc., Toronto, ON). Assessment of left ventricular (LV)
dimensions and systolic function was assessed using a short axis view in M-mode at the level
of the papillary muscle. Left ventricular (LV) diastolic filling and function was assessed using
pulsed wave doppler of transmitral blood flow velocities. These were located using color
imaging superimposed over an apical four-chamber view. Myocardial function assessment
was conducted using tissue doppler imaging (TDI) near the mitral annulus measured along
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the apical axis. Pulse wave velocity (PWV) determination within the aortic arch was made
via the determination of pulse transit time from the LV to a location measured proximally
along the ascending aortic arch and one measured distally along the thoracic descending
aorta. Distance between these points was measured using a B-mode image of this anatomical
segment. Aortic PWV was calculated as the difference in pulse transit time (calculated using
an ECG tracing as a reference) measured at these two points divided by the distance between
them.
Renal resistive index (RRI) was determined using pulsed doppler measurements
along the left main renal artery. RRI was calculated by taking the difference between systolic
and diastolic velocity divided by the diastolic velocity at that time point [98]. Data analysis
was performed offline using VevoLab and VevoVasc software (Fujifilm Visualsonics, Inc.,
Toronto, ON) in blinded fashion.
Analytical measurements and calculations
Hemodynamic Telemetry. Acquisition of hemodynamic data was conducted using
Ponemah software (Data Sciences International, MN). Systolic blood pressure (SBP),
diastolic blood pressure (DBP), mean arterial pressure (MAP), and heart rate (HR) were
sampled for 10 seconds every 4 minutes at a sampling rate of 500 samples/second. Pulse
pressure (PP) was calculated separately using these values. Baseline measurements were
averaged over three days after cage acclimation. Sampling was performed at this rate
continuously throughout Phases I and III within the metabolic cages.
Metabolic and Hormonal Assessment. Chow consumption was measured
gravimetrically daily and caloric and sodium (Na+) values were determined based on dietary
profiles for each feed.
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At the end of Phase III and prior to terminal harvest, food was removed from caging
at the beginning of the morning light cycles and terminal procedures were conducted at a
minimum of 6 hours later to promote a semi-fasting state (as permitted by our Animal Use
Committee). Glucose levels were determined using a One-Touch Ultra glucose monitor
(LifeScan, Inc., Malpitas, CA) on 50 µl blood from the arterial catheter. Arterial blood was
collected into pre-chilled tubes containing ethylenediaminetetraacetic acid (EDTA) for
plasma renin activity and into separate pre-chilled tubes containing 120 μL of 500 mM
sodium EDTA, 125 mM phenanthroline, 1 mM phenylmethanesulfonyl fluoride, 20 mM
pepstatin, 1 mM enalapril and 10X phosphatase inhibitor cocktail for insulin. Once collected,
blood was immediately centrifuged at 3000 rpm for 4 minutes at 4°C. Plasma was stored at
-70°C until assay. PRA and insulin levels were measured using a standard Elisa kits (IBL
International, Hamburg, Germany and Bertin Pharma SAS, Montingny-le-Bretonneux,
France, respectively) Insulin sensitivity was calculated using the ratio of plasma glucose to
insulin levels which was collected following a 6-hour minimum fasting period.
Rats were euthanized using sodium pentobarbital (120 mg/kg, IV) and hearts were
excised and preserved in formalin solution for 24-48 hours before embedding for
histological assessment.
Statistics. All values are presented as mean ± standard error (SE). One-way analysis
of variance (ANOVA) was used to determine differences among groups with a Sidak’s
multiple comparisons test for post‐hoc analysis. To limit unnecessary reductions in adjusted
statistical power resulting from excessive comparisons, once trends were discerned
individual Holm-Sidak’s tests were conducted on pre-selected groups. Two-way ANOVA’s
with repeated measures were performed to compare differences over time using a Sidak’s
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multiple comparisons test for post‐hoc analysis. A P-value less than 0.05 was considered
statistically significant. Due to the technical nature of many of these experimental techniques
that required data acquisition of pre-determined anatomic sites for rigorous and
reproducible analysis, N-values may differ across groups.
RESULTS
Caloric and sodium intakes. During baseline recordings, all rats in metabolic cages
were placed on a pair feeding paradigm. Due to small but measurable differences in caloric
profiles among diets, pair feeding was conducted using caloric consumption as an index
rather than direct chow weight. Despite careful attempts to match caloric intakes, statistical
differences among caloric intakes were observed following dietary changes from low salt to
high salt feeds in Phase I, week 1 (FHS group) and in Phase III weeks 1 and 2 (FLS-GHS, FHSGHS). Caloric intakes were no different among the groups by of week 2 of Phase I and III
except of the FLS-GHS group in Phase III that continued to ingest fewer calories (Table 4.1).
Low salt fed rats consumed approximately 10% of the amount of sodium consumed by high
salt fed rats consistent with their respective dietary sodium (Table 4.1).
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Table 4.1: Daily Consumption Measurements.
PHASE I
WEEK 1
Caloric
Sodium
Intake
Intake
(kcal/day)
(mmols/day)

WEEK 2
Caloric
Sodium
Intake
Intake
(kcal/day)
(mmols/day)

WEEK 3
Caloric
Sodium
Intake
Intake
(kcal/day)
(mmols/day)

DIETARY
REGIMEN

N

GLS

9

61.5±5

3.0± 0.3

68.4±4

3.0± 0.1

66.0±6

2.9± 0.1

FLS

9

60.7±8

2.7± 0.1

67.2±4

3.0± 0.1

65.7±5

3.2±0.3

FHS

19

51.9±7*

24.9±1.0*

63.9±4

30.9±1.8

64.0±5

31.0±2.3*

PHASE III
WEEK 1

WEEK 2

WEEK 3

DIETARY
REGIMEN

N

Caloric
Intake
(kcal/day)

Sodium
Intake
(mmols/day)

Caloric
Intake
(kcal/day)

Sodium
Intake
(mmols/day)

Caloric
Intake
(kcal/day)

Sodium
Intake
(mmols/day)

GLS‐GLS

9

62.6±6

2.8± 0.1

63.5±6

2.9± 0.1

64.3±5

2.8± 0.1

FLS‐GHS

9

45.9±5*

22.1±0.8*†

54.4±4*

26.2±0.7*

57.1±4†

27.5±0.6*

FHS‐GHS

8

50.1±7*

23.3±1.2*

56.1±6*

26.0±0.8*

59.9±6

27.7±0.6*

FHS‐FHS

9

60.5±5

27.5±0.8*

63.9±6

29.0±0.3*

66.4±8

29.9±1.0*

Table and data reconstituted from Chapter 3. Daily collection measurements recorded at 5 PM each day. Caloric
intake calculated using caloric profiles of 3.98 kcal/g and 3.61 kcal/g for low salt and high salt feed,
respectively. Values are indicated as mean ± SE, N as indicated per group; *p<0.05 vs. GLS-GLS controls; †-p<0.05 vs. FHS-FHS controls.

Hemodynamic effects. In Phase I, the addition of high salt in the diet of fructose fed
rats led to a progressive increase in mean arterial pressure that was significantly elevated
after four days (Data shown in Chapter 3, Figure 3.2). This increase was sustained for the
subsequent two weeks. By the end of Phase I, the MAP had risen in all groups consistent with
expected changes in blood pressure with maturation. Whereas the MAP did not differ among
the groups at the end of Phase I, the change between baseline and final MAP values in the
FHS group was statistically greater than that of other groups (P<0.01; Table 4.1A). The
addition of high dietary salt to the FLS-GHS and FHS-GHS groups in Phase III led to significant
increases in MAP within 1 week; levels which were maintained to the end of Phase III.
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Table 4.2: Hemodynamic Measurements.

A

PHASE I

PHASE 3

MAP
(MMHG)

GLS

FLS

FHS

GLS‐FHS

FLS‐GHS

FHS‐GHS

FHS‐FHS

BASELINE

100.7±0.6

100.7±2.5

99.9±3.5

109.3±1.9

111.9±1.1

111.2±1.8

113.7±1.7

DELTA

6.8±0.7

7.6±1.1

10.5±0.7**

0.5±0.5

4.0±1.1*

3.8±1.1*

2.0±1.1

B
DIETARY
REGIMEN
GLS‐GLS
FLS‐GHS
FHS‐GHS
FHS‐FHS

N

STUDY
Δ MAP
(MMHG)

STUDY
Δ SBP
(MMHG)

STUDY
Δ DBP
(MMHG)

STUDY
Δ HR
(BPM)

STUDY
Δ PP
(MMHG)

7
10.0±1.0
11±2.2
11±1.2
-92±11
2.4±1.5
8
15±0.9*
4.2±1.6
18±0.9*
14±1.3
-103±18
8
15±1.4*
18±1.7*
13±1.7
-105±6
4.2±2.0
8
16±2.0**
4.6±1.4
19±2.3**
14±1.9
-89±14
A.) Hemodynamic calculations for MAP throughout phases. N-values are as follows: GLS – 9, FLS – 7, FHS – 18.
B.) Study-wide changes in hemodynamics calculated as the difference between measurements taken at the end
of Phase III and the baseline measurements taken at the beginning of Phase I. Values are indicated as mean ±
SE, N as indicated per group; *p<0.05 vs. GLS-GLS controls, **p<0.01 vs. GLS-GLS controls.

After the rats that had received fructose in Phase I with either low salt or high salt,
were fed glucose-containing chow with high salt (FSL-GHS and FHS-GHS) or had been
maintained on fructose and high salt throughout the protocol (FHS-FHS), systolic blood
pressures at the end of Phase III had increased significantly compared with the GLS-GLS
group that had ingested glucose and low salt chow throughout the study (p<0.05). Diastolic
blood pressures did not differ across any of the groups; MAP was significantly greater only
in the FHS-FHS rats (p<0.01). Therefore, the increases in MAP were driven predominately
by systolic mechanisms. This did not, however, lead to a significant increase in pulse
pressure. Additionally, no differences existed among groups when heart rate was assessed.
Early and late impairment of vascular compliance. Echocardiography and
ultrasonography studies were performed immediately upon completion of Phases I and III.
Regional measurements of vascular compliance were taken throughout the aortic arch and
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the left main renal artery to assess PWV and RRI, respectively. In Phase I, FHS diet
significantly increased PWV of the thoracic aorta, thereby indicating decreased aortic
compliance compared to the GLS group (Figure 4.2). Maintenance of this diet throughout the
protocol led to a significant increase in PWV in Phase III in both the FHS-GHS and FHS-FHS
groups. No differences were observed in RRI of any of the groups at the end of Phase I (Figure
4.3). Similar to PWV values, FHS-GHS and FHS-FHS groups in Phase III displayed a
statistically higher RRI than GLS-GLS rats. These trends were only elevated in Phase III and
demonstrated no intra-group variability when compared to Phase I by two-way ANOVA.

Figure 4.2: Assessment of Aortic Compliance. Measurements used for the assessment of thoracic aortic
compliance in Phases 1 and 3. Values are indicated as mean ± SE, N values are as follows: GLS-8, FLS-8, FHS-18,
GLS-GLS – 8, FLS-GHS – 7, FHS-GHS – 8, FHS-FHS 10; *P<0.05 vs. GLS-GLS controls.
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Figure 4.3: Assessment of Renal Resistive Index (RRI). Conducted in Phases 1 and 3. Doppler imaging
measurements were made along the left main renal artery. Values are indicated as mean ± SE, N values are as
follows: GLS-9, FLS-6, FHS-16, GLS-GLS – 8, FLS-GHS – 9, FHS-GHS – 7, FHS-FHS - 9; *P<0.05 vs. GLS-GLS
controls.

Table 4.3: Echocardiographic Parameters Assessed at the End of Phase III.
Group

N
LVEF (%)
LVFS (%)
LVSID (mm)
LVDID (mm)
LVAW; Systole (mm)
LVAW; Diastole (mm)
LVPW; Systole (mm)
LVPW; Diastole (mm)
LVTW; Systole (mm)
LVTW; Diastole (mm)
LV Mass (mg)

GLS‐GLS
9
74.9±3.4
46.0±3.4
3.7±0.3
6.7±0.3
3.2±0.1
1.94±0.03
3.5±0.1
2.3±0.1
6.8±0.2
4.3±0.1
1190±73

FLS‐GHS
8
77.3±4.4
49.1±4.4
3.4±0.4
6.5±0.3
3.3±0.2
2.0±0.09
3.5±0.2
2.4±0.1
6.8±0.4
4.4±0.2
1060±59

FHS‐GHS
8
80.3±3.7
51.9±4.4
3.0±0.4
6.1±0.4
3.5±0.2
2.5±0.08**
4.0±0.3
3.0±0.3*
7.4±0.3
5.6±0.4**
1401±56*

FHS‐FHS
10
78.2±2.3
48.8±2.4
3.5±0.3
6.9±0.4
3.6±0.1
2.2±0.14*
4.0±0.2
2.7±0.2
7.6±0.4
4.9±0.3
1373.0±75*

Abbreviations: LVEF, left ventricular ejection fraction; LVFS, left ventricular fractional shortening; LVSID, left
ventricular systolic internal diameter; LVDID, left ventricular diastolic internal diameter; LVAW, left
ventricular anterior wall width; LVPW, left ventricular posterior wall width; LVTW, left ventricular total wall
width; LV Mass, Left ventricular mass. Values are mean ± SE, n as indicated per group; *P<0.05 vs. GLS-GLS
controls.

Echocardiographic assessment of dietary impacts. Physical assessment of the LV was
performed using a short axis view and M-mode imaging. Table 4.3 depicts the results of LV
echocardiography performed at the end of Phase III. No effect on standard systolic functional
measures such as ejection fraction and fractional shortening were observed. LV mass
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significantly increased in FHS-FHS and FHS-GHS test groups. Further assessment of
structural morphology found changes in anterior and posterior wall thickness in FHS-GHS
groups; these changes were more only significant during diastole. In the FHS-FHS group LV
thickness only reached significance in the anterior wall. When assessed as a ratio of total
wall thickness (sum of anterior and posterior walls) to diastolic diameter (radius cavity),
there was a significant reduction in the ratio in FHS-GHS rats when compared with that of
the GLS-GLS group (Figure 4.4). Taken together these measurements are indicative of
ventricular hypertrophy and concentric remodeling.

Figure 4.5. Assessment of Left Ventricular Morphology in Phase III. Conducted under a short axis view of
the left ventricle using M-Mode. Total wall thickness is assessed as the sum of anterior and posterior LV wall
widths and LV Wall/Radius cavity is assessed as the ratio of total wall thickness and end-diastolic diameter.
Table 4.4 depicts further functional assessment conducted by way of pulsed and
Values are indicated as mean ± SE, N as indicated per group; *P<0.05 vs. GLS-GLS controls.
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tissue doppler imaging of the mitral valve area. The ratio of early to late phase filling (E/A)
demonstrated significant reductions in the FHS-FHS group. Values for E/A in Phase I and III,
respectively, are shown in Figure 4.5. Reductions in the E/A ratio in the FLS-GHS and FHSGHS test groups were also observed, although these values did not achieve significance.
Likewise, decreases in mitral valve deceleration time were also observed across all groups
when compared to the GLS-GLS group, however these were only significant in the FHS-FHS
group. In contrasting to these abnormal flow patterns, TDI did not observe any remarkable
differences among groups.
Table 4.4: Parameters Associated with Diastolic Function Assessed at the End of Phase
III.

Group
N
Peak E (mm/s)
Peak A (mm/s)
E/A
DT (ms)
IVRT (ms)
E’(mm/s)
A’(mm/s)
E/E’
E’/A’

GLS‐GLS

FLS‐GHS

FHS‐GHS

FHS‐FHS

9
706±22
555±27
1.31±0.06
39.5±4.0
25.5±1.0
34.1±2.6
45.3±3.7
22.5±1.9
0.81±0.01

8
630±45
550±44
1.16±0.06
28.0±2.2*
27.7±1.5
32.3±4.6
45.8±4.7
25.2±6.2
0.71±0.09

8
652±41
576±34
1.14±0.06*
31.8±3.0
27.6±1.1
34.2±4.0
48±4.9
21.1±3.3
0.81±0.15

10
641±39
621±32
1.03±0.04**
25.4±2.3**
29.0±0.9ł
27.4±1.8
47.1±4.7
24.3±2.3
0.64±0.01

Abbreviations: E, early phase ventricular filling; A, late phase ventricular filling; DT, mitral valve deceleration
time; MV Area, mitral valve area; IVRT, isovolumetric relaxation time; E’, mitral annulus early phase filling; A’
Values are mean ± SE, n as indicated per group; *p<0.05 vs. GLS-GLS controls, **p<0.01 vs. GLS-GLS controls.
łp<0.05 vs. GLS-GLS controls via unpaired student’s t-test.
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Figure 4.5: Assessment of Diastolic Function. Assessment of blood flow across the mitral valve as an
indicator of diastolic function using the ratio of early phase left ventricular filling (E-Wave) and late phase left
ventricular filling induced by atrial contraction (A-Wave) Values are indicated as mean ± SE, GLS-9, FLS-7, FHS18, GLS-GLS – 10, FLS-GHS – 9, FHS-GHS – 9, FHS-FHS - 10; *p<0.05 vs. GLS-GLS controls, **p<0.01 vs. GLS-GLS
controls.

Metabolic profiles are shown in Table 4.5. Initial weights and final weights
demonstrated no differences among rats on different dietary regimens. FLS-GHS fed rats had
a small, but insignificantly lower final body weight which was attributed to reduced caloric
consumption at the beginning of Phase III following the change in chow from glucose with
low salt to glucose with high salt content. Plasma glucose and insulin levels did not vary
among the groups and were comparable to either vendor specifications for standard
Sprague-Dawley rats on standard diets and rats fed control diets with no added sugar in
similar studies [193-195]. Glucose: insulin ratio was significantly lower in the FHS-GHS
group compared with GLS-GLS and FLS-GHS groups. FHS-FHS rats had an attenuated
glucose:insulin ratio, but this was not significant. PRA was significantly reduced in FLS-GHS
groups following high salt challenge at the end of Phase III. FHS-FHS rats had a similar, albeit
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slightly blunted, inhibition of renin secretion that has been witnessed in prior studies [42].
Following high salt challenge, PRA was lower in FHS-GHS rats compared with GLS-GLS rats
but did not achieve significance.
Table 4.5: Metabolic and Endocrine Assessment.
N
9

Initial
weight
(g)
125±4

Final
Weight
(g)
381±9

Heart
Weight
(g/kg)
3.3±0.1

Fasting
Glucose
(mg/dL)
128±13

Fasting
Insulin
(ng/mL)
1.14±0.23

G:I Ratio
(x106)
64.7±6.4

PRA
(ng Ang I
/mL/Hr)
1.82±0.20

FLS‐GHS

9

132±4

347±10

3.4±0.1

129±24

0.74±0.12

74.6±12.6

0.66±0.12**

FHS‐GHS

8

128±3

362±12

3.2±0.1

126±14

1.33±0.12

31.6±1.9*

1.35±0.28

FHS‐FHS

9

127±5

366±12

3.4±0.1

118±11

1.03±0.17

43.0±8.3

1.09±0.29*

Dietary
Regimen
GLS‐GLS

Assay values conducted using blood samples collected through an intra-arterial line extracted under conscious
conditions. Rats were fasted for a minimum of 6 hours prior to collection. Values are indicated as mean ± SE, N
as indicated per group; *P<0.05 vs. GLS-GLS controls, **P<0.01 vs. GLS-GLS controls. Due to technical
complications, G:I (Glucose:Insulin) ratio N values differ and are as follows: GLS-GLS -5 , FLS-GHS - 6, FHS-GHS
- 7, FHS-FHS - 7. *NOTE: Table adapted from Chapter 3, Table 4.

DISCUSSION
The major findings of this study support the hypothesis that fructose plus high salt
programming early in life can have profound cardiovascular impacts in adulthood following
the addition of high dietary sodium. Chronic feeding of FHS diet in our FHS-FHS group
elicited more pronounced consequences than noted in prior studies conducted by our lab
such as reduced aortic compliance and diastolic dysfunction [163]. Of note is the similar –
findings in cardiovascular parameters in FHS-GHS and FHS-FHS groups.
The addition of high salt to rats primed with a fructose diet elicits an increase in MAP
driven by significant increases in systolic blood pressure. Slight increases in diastolic blood
pressure occurred which prevented any statistically significant increases in pulse pressure.
Study-wide increases in MAP where similar throughout all 3 groups fed with fructose.
However, the statistically elevated MAP in the FLS-GHS groups were the result of the large
increases observed in Phase III following high salt challenge. This alludes to the likelihood
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that fructose alone (without the addition of high salt) is sufficient to chronically predispose
the kidney to states of heightened salt-sensitivity that can lead to hypertension. Although the
FLS-GHS group reach similar extents of hypertension, the problematic maladaptation of
vascular stiffening and LV dysfunction were not as apparent as in other groups.
Pathologies underlying fructose-induced hypertension are increased sympathetic
activity, endothelial dysfunction, and increased sodium retention leading to increased
extracellular volume [52, 77]. Increased extracellular volume in the FHS group of Phase I is
likely to play a large role in producing the increases in MAP. Increased extracellular volume
is unlikely to be the only governing factor in prolonged FHS feeding, however. Indeed,
increased arterial pressure over time alone can induce cellular and molecular alterations
that deform the vascular wall [109]. Further, prolonged fructose feeding is associated with
hyperinsulinemia which can cause increased circulating levels of endothelin-1 (ET-1), Ang
II, and uric acid [32, 80, 196, 197]. It is of note that no significant differences in insulin levels
or calculated insulin resistance via our modified G:I ratio approach were observed among
groups. No evidence of hyperglycemia was present either. While it cannot be definitively
concluded in this study that altered insulin signaling had no effect, the impact was likely
nominal. Alternative pathologies such as reactive oxygen species (ROS) are more likely
implicated in the observed endothelial dysfunction [66, 163].
Evidence of vascular dysfunction becomes evident in FHS groups by the end of Phase
I as demonstrated by increased PWV, but in Phase III this effect becomes exacerbated in FHSFHS groups both when compared to Phase III GLS-GLS controls as well as when compared to
initial Phase I measurements using 2-way ANOVA with repeated measures. FHS-GHS fed rats
exhibit a significant increase in PWV in Phase III that was not significantly elevated from
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Phase I. Whether this is residual arterial dysfunction from Phase I or the result of additional
factors is unclear. However, PRA was not significantly reduced from GLS-GLS controls at the
time of terminal harvest despite the positive sodium balance observed in the FHS-GHS group.
These levels differed from the significantly reduced PRA levels in FLS-GHS and FHS-FHS
groups, indicating a contribution of the RAAS in maintaining the elevated MAP by the end of
Phase III.
Numerous studies have been conducted to determine the capacity for clinical
applicability of the renal resistive index (RRI) in determining renal function in association
with the progression of hypertension, chronic nephropathy, and diabetes mellitus [198201]. Further, many additional studies have found functional correlation between elevated
RRI and intrarenal perfusion and renovascular resistance, but also correlation to various
pathological conditions that occur in many of the above-mentioned diseases, such as
tubulointerstitial damage and renal atherosclerosis [202-204].
While there is still controversy over the reliability of RRI as a measurement across all
diseases [205], there is a general consensus regarding its relation to adverse cardiac and
renal outcomes in hypertension [206, 207]. We observed significant increases in RRI in FHSFHS and FHS-GHS groups only in Phase III. In some circumstances, the increase in renal
artery resistance is a product of prolonged activation and/or resetting of renal
autoregulatory mechanisms such as the myogenic response or tubuloglomerular feedback
[208]. However, given the unremarkable response in RRI in the FLS-GHS group but statistical
increase in FHS-GHS group to high salt challenge, it is unlikely that autoregulatory
mechanisms play a significant role. Alternatively, renal resistance is also suspectable to
changes in upstream and downstream vascular compliance and has been correlated to
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increased pulsatility [98]. Concurrent with this theory is the decreased thoracic aortic
compliance (calculated by PWV) observed in this present study.
Total peripheral resistance is a function of MAP and heart rate - an increase in either
factor without a corresponding decrease in the other elevates total peripheral resistance
[209]. In this study, this physiologic dysfunction is observed as both an increase in general
systemic resistance and in lack of local aortic compliance. The net effect of these factors is an
increase in ventricular afterload which can lead to left ventricular remodeling and
subsequent hypertrophy [210]. Prior to the development of heart failure are the occurrence
of early signs and symptoms of ventricular remodeling and mechanical dysfunction [211].
The significantly reduced E/A ratio in both FHS-GHS and FHS-FHS groups was evidence of
diastolic dysfunction. In each of these groups ventricular wall sizes were increased, although
this only statistically significant in FHS-GHS groups when compared to GLS-GLS controls.
This implies hypertrophic growth that when assessed as a ratio of ventricular wall thickness
to end-diastolic cavity size, a significant increase is observed. These changes did not result,
however, in an overall increase in cardiac mass. These findings are consistent with
concentric remodeling of the heart which is generally induced by chronic conditions of
pressure-overload, such as in hypertension [212].
Whereas ventricular remodeling was not as pronounced in rats chronically fed FHS
chow compared to the FHS-GHS group, mechanical dysfunction was more distinct. The
decrease in the ratio of early to late diastolic filling was accompanied by an increase in
isovolumetric relaxation time and decrease in mitral valve deceleration time. Mitral valve
area is contrived from deceleration time and was therefore significantly increased.
Shortening of the mitral valve deceleration time implies restrictive filling and has been
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positively correlated to severe adverse cardiac events [213]. Each of these measurements
are indicative of diastolic dysfunction and are phenotypes associated with either the
development or presence of cardiomyopathy [214-216].
Limitations
Due to the overall protocol time length and material requirements, it was necessary
to implement experimental group limitations to maintain consistent and equal allotment of
animals into specified groups throughout each batch. Previous studies from differing labs
have found no significant changes in arterial pressure or bodily sodium balance in rats fed a
glucose and high salt diet in both acute and chronic settings. Concurrent with this are
observations of no change in ultrasound and echocardiography studies. While the timeline
of the study at present exceeds that of prior studies, we feel that our current choice of
negative (GLS-GLS) and positive (FHS-FHS) control groups was sufficient to satisfactorily
demonstrate changes associated with short term administration of high salt diet later in life.
Sex hormones play an important role in the development of hypertension following a
high fructose diet. Female rats have been shown to be particularly resistant to the
development of insulin resistance and therefore hyperinsulinemia specifically due to the
presence of differing sex hormones. The purpose of this model is to demonstrate that
hypertension can be induced using dietary regimens relevant to moderate consumption
levels observed in modern society, and therefor with limited effects of insulin. While these
effects are limited, they cannot be entirely negated; effective comparisons among groups
with previous findings therefore necessitated the use of only one sex. Studies in female rats
will be needed in the future.
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Perspectives
Several studies demonstrating the effects of chronic carbohydrate consumption and
the development of cardiomyopathy and heart failure exist, but these specifically rely on the
development of diabetes and the associated pathologies [214, 217]. Hyperglycemia,
hyperinsulinemia, and insulin resistance are associated even with pre-diabetic states and
play an important role in developing the observed cardiovascular abnormalities [186]. In
the present study we did not find remarkable evidence of any of these pathologies. The
administration of free radical scavengers in this model prevents the development of
hypertension and ameliorates aortic stiffening in matured rats [66, 163]. The vascular insults
observed via ultrasound following Phase I grew progressively worse in the FHS-FHS controls
and likely played a considerable pathologic role in the developed diastolic dysfunction. As
the FLS-GHS groups did not display any aortic stiffening following the high salt challenge in
Phase III, it can be speculated that what was observed in the FHS-GHS group was in part
residual reductions in compliance from Phase I that may have been exacerbated by the
addition of high dietary sodium. Alternatively, the exposure to both fructose and high salt
early in life in Phase I is an important factor for later development of the vasculopathy and
cardiomyopathy.
On the other hand, fructose feeding alone, without the addition of high dietary sodium
during the critical developmental period is sufficient to induce as state of salt-sensitivity
later in life which renders the body susceptible to hypertension. Chronically this can lead to
various cardiac and renal co-morbidities such as heart failure and chronic kidney disease
[218, 219]. Even FLS-GHS groups that became hypertensive only later in life had a reduction
in diastolic function, indicated by the E/A ratio, but this was not significant. Contrastingly,
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the addition of high salt to a moderate fructose diet during pubescent, developmental years
had lasting effects on cardiac and renal function evidenced by diastolic dysfunction,
ventricular hypertrophy, and failed renin suppression. This detriment occurred in rats that
were fed this fructose and high salt diet chronically and those that were allowed a period of
reprise from poor dietary conditions (FHS-GHS) groups. Indeed, diets with fructose fed early
in life - with or without the presence of elevated sodium - promote adaptations that render
the body increasingly vulnerable to complications caused by even modest dietary insults;
these insults are long lasting and with severe consequence.
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CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS
The present studies indicate that consumption of even a moderate fructose diet
induces states of salt-sensitivity that can result in hypervolemia and rapid induction of
hypertension. The robust initial increase in arterial pressure does not necessarily continue
to progress as numerous regulatory mechanisms such as diuresis become increasingly
active. While these responses are sufficient to curb the rising arterial pressure, they are
unable to entirely restore normotensive states, indicating abnormally functioning regulatory
systems. The result is a modest overall increase in arterial pressure that can lead to
cardiovascular and renal dysfunction in relatively short periods of time.
Whereas further studies are necessary to determine the permanence of fructoseinduced complications, it is apparent from the studies at present that provision of fructose
during developmental periods in youth leads to a programmed salt-sensitivity which extend
into adulthood. In this model the salt-sensitivity is driven by renal mechanisms. A
particularly novel observation made in these studies was that this state of salt-sensitivity is
no longer dependent on the concomitant consumption of fructose. Further, the increases in
arterial pressure that arise from the addition of high dietary sodium are accompanied by
phonotypes of cardiovascular and renal dysfunction similar in nature and extent to those of
rats chronically fed a fructose and high sodium diet since early adolescence.
The ratio of early to late phase ventricular filling (E/A ratio) assessed via trans-mitral
flow imaging is effectively the most reliable indicator of diastolic function. Unfortunately,
there is an inherent degree of bluntness behind its use as it serves as an overall index of
function and provides very little mechanistic insight, thereby necessitating several other
measurements to not only confirm the presence of dysfunction, but also to determine the
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precise pathologic origins. Furthermore, it is subject to error particularly in animal models
where heart rate is much higher than that of a human. Indeed, subjects with elevated resting
heart rates make not only the discernment of E and A waves challenging, but it can also affect
the magnitude itself of each wave form [220]. Such inaccuracies can ultimately sufficiently
affect statistical analyses such that observable trends become dismissed.
The dismissal of such trends is not indicative of Type 1 error so much as it is a result
of various pitfalls associated with standard echocardiography. Regional measurements of
the rate of deformation by which cardiac fibers displace themselves throughout the cardiac
cycle, also known as strain and strain rate assessment, provides a unique methodology by
which to measure changes in cardiac function. This technique observes trends in myocardial
detriment with greater sensitivity and is favorable in instances in which frank cardiac
disturbances are only beginning to manifest, such as in early stages of diabetes. Particularly
in FLS-GHS groups, where the E/A ratio declined but ultimately did not reach significance,
strain and strain rate assessment may provide additional insight. Furthermore, this
technique may reveal preliminary changes that occur in youth that were previously
unobservable. The subtlety by which diastolic dysfunction occurs in this model warrants
further investigation. Early detection of these malignant adaptations is critical for the
employment of interventional strategies in the prevention of severe future complications.
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Dietary consumption of fructose facilitates increased intestinal fluid absorption and
renal sodium reabsorption, thereby increasing fluid retention. The net result of this is a
sustained increased in extracellular fluid volume that leads to states of hypervolemia and
subsequent hypertension. Simultaneously, arterial pressure is being elevated by increased
autonomic drive stemming from the sympathetic nervous system and various other
endovascular proteins that induce vasoconstriction. Under these conditions, the addition of
high dietary sodium promotes hypertension prior to the development of significant
metabolic disturbances; the subtlety of which may go unnoticed by patients for prolonged
periods. While much is understood regarding the multifactorial pathologies of this model of
hypertension, few studies have investigated the chronic effects of this disease and the endorgan damage that may result. The highest consumers of fructose are adolescents and young
adults, and despite this demographic factor a disparity in the amount of research
investigating the chronic effects of such a diet on developing physiologic systems exists.
Using techniques such ultrasonography, telemetry, and metabolic caging systems, we sought
to determine the acute and chronic effects of fructose and high salt feeding in both adult and
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adolescent rats. The results of these studies confirmed conclusions from prior studies in that
fructose induces a state of salt-sensitivity. Over time this prolonged period of hypertension
eventually leads to diastolic dysfunction and left ventricular hypertrophy. The novel-most
finding of this study, however, was the discovery that fructose feeding at a young age induces
salt-sensitive states governed by renal mechanisms and that this sensitivity is retained into
adulthood even following the restoration of a healthy diet. Taken together, these results
indicate the inherent risks associated with moderate fructose consumption and highlight the
importance healthy dietary habits in promoting cardiovascular and renal health throughout
life.
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